UNITED STATES | ||||||||||||||
SECURITIES AND EXCHANGE COMMISSION | ||||||||||||||
WASHINGTON, D.C. 20549 | ||||||||||||||
FORM |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||||||||
For the Quarterly Period Ended | ||||||||||||||
OR | ||||||||||||||
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||||||||||||
For the Transition Period from_______________________to_______________________ |
Commission File No. |
(Exact name of registrant as specified in its charter) |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: |
Former name, former address and former fiscal year, if changed since last report: | Not Applicable |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days | ☒ | No | ☐ |
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). | ☒ | No | ☐ |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | |||||||||||
Large Accelerated Filer | ☐ | Accelerated Filer | ☐ | ||||||||
☒ | Smaller reporting company | ||||||||||
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | Yes | No | ☒ |
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. | ||||||||||||||
Class | Outstanding at May 10, 2021 | |||||||||||||
Common Stock (par value $30 per share) | ||||||||||||||
THE REGISTRANT MEETS THE CONDITIONS SET FORTH IN GENERAL INSTRUCTIONS H(1) (a) AND (b) OF FORM 10-Q AND IS THEREFORE FILING THIS FORM WITH THE REDUCED DISCLOSURE FORMAT. | ||||||||||||||
Part I. Financial Information | |||||||||||
Item 1. Financial Statements (Unaudited) | |||||||||||
Consolidated Balance Sheets — March 31, 2021 and December 31, 2020 | |||||||||||
Consolidated Statements of Income — Three months ended March 31, 2021 and 2020 | |||||||||||
Consolidated Statements of Comprehensive Income — Three months ended March 31, 2021 and 2020 | |||||||||||
Consolidated Statements of Shareholder’s Equity — Three months ended March 31, 2021 and 2020 | |||||||||||
Consolidated Statements of Cash Flows — Three months ended March 31, 2021 and 2020 | |||||||||||
Notes to Consolidated Financial Statements | |||||||||||
1. | Basis of Presentation | ||||||||||
2. | Recent Accounting Pronouncements | ||||||||||
3. | Revenue from Contracts with Customers | ||||||||||
4. | Variable Interest Entities | ||||||||||
5. | Investments | ||||||||||
6. | Financing Receivables | ||||||||||
7. | Deferred Acquisition Costs and Deferred Sales Inducement Costs | ||||||||||
8. | Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | ||||||||||
9. | Variable Annuity and Insurance Guarantees | ||||||||||
10. | Debt | ||||||||||
11. | Fair Values of Assets and Liabilities | ||||||||||
12. | Offsetting Assets and Liabilities | ||||||||||
13. | Derivatives and Hedging Activities | ||||||||||
14. | Shareholders’ Equity | ||||||||||
15. | Income Taxes | ||||||||||
16. | Contingencies | ||||||||||
Item 2. Management’s Narrative Analysis | |||||||||||
Item 4. Controls and Procedures | |||||||||||
Part II. Other Information | |||||||||||
Item 1. Legal Proceedings | |||||||||||
Item 1A. Risk Factors | |||||||||||
Item 6. Exhibits | |||||||||||
Signatures |
March 31, 2021 | December 31, 2020 | ||||||||||
(in millions, except share amounts) | |||||||||||
Assets | |||||||||||
Investments: | |||||||||||
Available-for-Sale: Fixed maturities, at fair value (amortized cost: 2021, $ | $ | $ | |||||||||
Mortgage loans, at amortized cost (allowance for credit losses: 2021 and 2020, $ | |||||||||||
Policy loans | |||||||||||
Other investments (allowance for credit losses: 2021, $ | |||||||||||
Total investments | |||||||||||
Investments of consolidated investment entities, at fair value | |||||||||||
Cash and cash equivalents | |||||||||||
Cash of consolidated investment entities | |||||||||||
Reinsurance recoverables (allowance for credit losses: 2021, $ | |||||||||||
Other receivables | |||||||||||
Receivables of consolidated investment entities, at fair value | |||||||||||
Accrued investment income | |||||||||||
Deferred acquisition costs | |||||||||||
Other assets | |||||||||||
Other assets of consolidated investment entities, at fair value | |||||||||||
Separate account assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities and Shareholder’s Equity | |||||||||||
Liabilities: | |||||||||||
Policyholder account balances, future policy benefits and claims | $ | $ | |||||||||
Short-term borrowings | |||||||||||
Debt of consolidated investment entities, at fair value | |||||||||||
Long-term debt | |||||||||||
Other liabilities | |||||||||||
Other liabilities of consolidated investment entities, at fair value | |||||||||||
Separate account liabilities | |||||||||||
Total liabilities | |||||||||||
Shareholder’s equity: | |||||||||||
Common stock, $ | |||||||||||
Additional paid-in capital | |||||||||||
Accumulated deficit | ( | ( | |||||||||
Accumulated other comprehensive income, net of tax | |||||||||||
Total shareholder’s equity | |||||||||||
Total liabilities and shareholder’s equity | $ | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Revenues | |||||||||||
Premiums | $ | $ | |||||||||
Net investment income | |||||||||||
Policy and contract charges | |||||||||||
Other revenues | |||||||||||
Net realized investment gains (losses) | ( | ||||||||||
Total revenues | |||||||||||
Benefits and expenses | |||||||||||
Benefits, claims, losses and settlement expenses | ( | ||||||||||
Interest credited to fixed accounts | |||||||||||
Amortization of deferred acquisition costs | |||||||||||
Interest and debt expense | |||||||||||
Other insurance and operating expenses | |||||||||||
Total benefits and expenses | ( | ||||||||||
Pretax income | |||||||||||
Income tax provision | |||||||||||
Net income | $ | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Net income | $ | $ | |||||||||
Other comprehensive income (loss), net of tax: | |||||||||||
Net unrealized gains (losses) on securities | ( | ( | |||||||||
Total other comprehensive income (loss), net of tax | ( | ( | |||||||||
Total comprehensive income | $ | ( | $ |
Common Shares | Additional Paid-In Capital | Retained Earnings (Deficit) | Accumulated Other Comprehensive Income (Loss) | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balances at January 1, 2020 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Cumulative effect of adoption of current expected credit losses guidance | — | — | ( | — | ( | ||||||||||||||||||||||||
Comprehensive income (loss): | |||||||||||||||||||||||||||||
Net income (loss) | — | — | — | ||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | ( | ( | ||||||||||||||||||||||||
Total comprehensive income (loss) | |||||||||||||||||||||||||||||
Cash dividends to Ameriprise Financial, Inc. | — | — | ( | — | ( | ||||||||||||||||||||||||
Balances at March 31, 2020 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Balances at January 1, 2021 | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||
Comprehensive income (loss): | |||||||||||||||||||||||||||||
Net income (loss) | — | — | — | ||||||||||||||||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | ( | ( | ||||||||||||||||||||||||
Total comprehensive income (loss) | ( | ||||||||||||||||||||||||||||
Cash dividends to Ameriprise Financial, Inc. | — | — | ( | — | ( | ||||||||||||||||||||||||
Balances at March 31, 2021 | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Cash Flows from Operating Activities | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||||||||
Depreciation, amortization and accretion, net | ( | ( | |||||||||
Deferred income tax (benefit) expense | ( | ||||||||||
Contractholder and policyholder charges, non-cash | ( | ( | |||||||||
Loss from equity method investments | |||||||||||
Net realized investment (gains) losses | ( | ( | |||||||||
Impairments and provision for loan losses | ( | ||||||||||
Net losses (gains) of consolidated investment entities | ( | — | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Deferred acquisition costs | ( | ||||||||||
Policyholder account balances, future policy benefits and claims, net | ( | ||||||||||
Derivatives, net of collateral | ( | ||||||||||
Reinsurance recoverables | ( | ||||||||||
Other receivables | |||||||||||
Accrued investment income | ( | ( | |||||||||
Current income tax expense (benefit) | ( | ||||||||||
Payable for investment securities purchase | — | ||||||||||
Other, net | |||||||||||
Net cash provided by (used in) operating activities | ( | ||||||||||
Cash Flows from Investing Activities | |||||||||||
Available-for-Sale securities: | |||||||||||
Proceeds from sales | |||||||||||
Maturities, sinking fund payments and calls | |||||||||||
Purchases | ( | ( | |||||||||
Proceeds from sales, maturities and repayments of mortgage loans | |||||||||||
Funding of mortgage loans | ( | ( | |||||||||
Proceeds from sales and collections of other investments | |||||||||||
Purchase of other investments | ( | ( | |||||||||
Purchase of investments by consolidated investment entities | ( | — | |||||||||
Proceeds from sales, maturities and repayments of investments by consolidated investment entities | — | ||||||||||
Purchase of equipment and software | ( | ( | |||||||||
Change in policy loans, net | ( | ||||||||||
Cash paid for deposit receivable | ( | ( | |||||||||
Cash received for deposit receivable | |||||||||||
Advance on line of credit to Ameriprise Financial, Inc. | |||||||||||
Repayment from Ameriprise Financial, Inc. on line of credit | ( | ||||||||||
Cash received from written options with deferred premiums | |||||||||||
Cash paid for written options with deferred premiums | ( | ( | |||||||||
Other, net | ( | ||||||||||
Net cash provided by (used in) investing activities | ( | ( | |||||||||
See Notes to Consolidated Financial Statements. |
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (continued) | |||||||||||
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Cash Flows from Financing Activities | |||||||||||
Policyholder account balances: | |||||||||||
Deposits and other additions | $ | $ | |||||||||
Net transfers from (to) separate accounts | ( | ||||||||||
Surrenders and other benefits | ( | ( | |||||||||
Proceeds from line of credit with Ameriprise Financial, Inc. | |||||||||||
Payments on line of credit with Ameriprise Financial, Inc. | ( | ||||||||||
Cash received for purchased options with deferred premiums | |||||||||||
Cash paid for purchased options with deferred premiums | ( | ( | |||||||||
Borrowings by consolidated investment entities | — | ||||||||||
Repayments of debt by consolidated investment entities | ( | — | |||||||||
Cash dividends to Ameriprise Financial, Inc. | ( | ( | |||||||||
Net cash provided by (used in) financing activities | ( | ||||||||||
Net increase (decrease) in cash and cash equivalents | ( | ||||||||||
Cash and cash equivalents at beginning of period | |||||||||||
Cash and cash equivalents at end of period | $ | $ | |||||||||
Supplemental Disclosures: | |||||||||||
Income taxes paid (received), net | $ | $ | |||||||||
Interest paid on borrowings | — | ||||||||||
Non-cash investing activity: | |||||||||||
Partnership commitments not yet remitted | — | ||||||||||
Exchange of an investment that resulted in a realized gain and an increase to amortized cost | — | ||||||||||
See Notes to Consolidated Financial Statements. |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Policy and contract charges | |||||||||||
Affiliated | $ | $ | |||||||||
Unaffiliated | |||||||||||
Total | |||||||||||
Other revenues | |||||||||||
Administrative fees | |||||||||||
Affiliated | |||||||||||
Unaffiliated | |||||||||||
Other fees | |||||||||||
Affiliated | |||||||||||
Unaffiliated | |||||||||||
Total | |||||||||||
Total revenue from contracts with customers | |||||||||||
Revenue from other sources (1) | |||||||||||
Total revenues | $ | $ |
March 31, 2021 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Investments: | |||||||||||||||||||||||
Common stocks | $ | — | $ | $ | — | $ | |||||||||||||||||
Syndicated loans | — | ||||||||||||||||||||||
Total investments | — | ||||||||||||||||||||||
Receivables | — | — | |||||||||||||||||||||
Other assets | — | — | |||||||||||||||||||||
Total assets at fair value | $ | — | $ | $ | $ | ||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Debt (1) | $ | — | $ | $ | — | $ | |||||||||||||||||
Other liabilities | — | — | |||||||||||||||||||||
Total liabilities at fair value | $ | — | $ | $ | — | $ |
December 31, 2020 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
Investments: | |||||||||||||||||||||||
Corporate debt securities | $ | — | $ | $ | — | $ | |||||||||||||||||
Common stocks | — | — | |||||||||||||||||||||
Syndicated loans | — | ||||||||||||||||||||||
Total investments | — | ||||||||||||||||||||||
Receivables | — | — | |||||||||||||||||||||
Other assets | — | — | |||||||||||||||||||||
Total assets at fair value | $ | — | $ | $ | $ | ||||||||||||||||||
Liabilities | |||||||||||||||||||||||
Debt (1) | $ | — | $ | $ | — | $ | |||||||||||||||||
Other liabilities | — | — | |||||||||||||||||||||
Total liabilities at fair value | $ | — | $ | $ | — | $ |
Syndicated Loans | Other Assets | ||||||||||
(in millions) | |||||||||||
Balance, January 1, 2021 | $ | $ | |||||||||
Total gains (losses) included in: | |||||||||||
Net income | — | ||||||||||
Purchases | — | ||||||||||
Sales | ( | — | |||||||||
Settlements | ( | — | |||||||||
Transfers into Level 3 | — | ||||||||||
Transfers out of Level 3 | ( | ( | |||||||||
Balance, March 31, 2021 | $ | $ | |||||||||
Changes in unrealized gains (losses) included in income relating to assets held at March 31, 2021 | $ | $ | — |
March 31, 2021 | December 31, 2020 | ||||||||||
(in millions) | |||||||||||
Syndicated loans | |||||||||||
Unpaid principal balance | $ | $ | |||||||||
Excess unpaid principal over fair value | ( | ( | |||||||||
Fair value | $ | $ | |||||||||
Fair value of loans more than 90 days past due | $ | $ | |||||||||
Fair value of loans in nonaccrual status | |||||||||||
Difference between fair value and unpaid principal of loans more than 90 days past due, loans in nonaccrual status or both | |||||||||||
Debt | |||||||||||
Unpaid principal balance | $ | $ | |||||||||
Excess unpaid principal over fair value | ( | ( | |||||||||
Carrying value (1) | $ | $ |
Carrying Value | Weighted Average Interest Rate | ||||||||||||||||||||||
March 31, 2021 | December 31, 2020 | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Debt of consolidated CLOs due 2025-2034 | $ | $ | % | % |
Description of Securities | March 31, 2021 | |||||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||
Corporate debt securities | $ | $ | $ | ( | $ | — | $ | |||||||||||||||||||||||||
Residential mortgage backed securities | ( | — | ||||||||||||||||||||||||||||||
Commercial mortgage backed securities | ( | — | ||||||||||||||||||||||||||||||
State and municipal obligations | ( | — | ||||||||||||||||||||||||||||||
Asset backed securities | — | — | ||||||||||||||||||||||||||||||
Foreign government bonds and obligations | ( | — | ||||||||||||||||||||||||||||||
Total | $ | $ | $ | ( | $ | — | $ |
Description of Securities | December 31, 2020 | |||||||||||||||||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value | ||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||
Corporate debt securities | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||
Residential mortgage backed securities | ( | — | ||||||||||||||||||||||||||||||
Commercial mortgage backed securities | ( | — | ||||||||||||||||||||||||||||||
State and municipal obligations | ( | — | ||||||||||||||||||||||||||||||
Asset backed securities | ( | — | ||||||||||||||||||||||||||||||
Foreign government bonds and obligations | ( | — | ||||||||||||||||||||||||||||||
U.S. government and agency obligations | — | — | — | |||||||||||||||||||||||||||||
Total | $ | $ | $ | ( | $ | ( | $ |
Ratings | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||||||||||
Amortized Cost | Fair Value | Percent of Total Fair Value | Amortized Cost | Fair Value | Percent of Total Fair Value | |||||||||||||||||||||||||||||||||
(in millions, except percentages) | ||||||||||||||||||||||||||||||||||||||
AAA | $ | $ | % | $ | $ | % | ||||||||||||||||||||||||||||||||
AA | ||||||||||||||||||||||||||||||||||||||
A | ||||||||||||||||||||||||||||||||||||||
BBB | ||||||||||||||||||||||||||||||||||||||
Below investment grade | ||||||||||||||||||||||||||||||||||||||
Total fixed maturities | $ | $ | % | $ | $ | % |
Description of Securities | March 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of Securities | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | ||||||||||||||||||||||||||||||||||||||||||||||||
(in millions, except number of securities) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities | $ | $ | ( | $ | $ | — | $ | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgage backed securities | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage backed securities | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
State and municipal obligations | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign government bonds and obligations | — | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | $ | ( | $ | $ | ( |
Description of Securities | December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Number of Securities | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | Number of Securities | Fair Value | Unrealized Losses | ||||||||||||||||||||||||||||||||||||||||||||||||
(in millions, except number of securities) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate debt securities | $ | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||||||||||||||||||||||||||||||||||||||||
Residential mortgage backed securities | ( | — | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Commercial mortgage backed securities | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
State and municipal obligations | — | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Asset backed securities | — | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Foreign government bonds and obligations | — | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | $ | ( | $ | $ | ( |
Corporate Debt Securities | |||||
(in millions) | |||||
Balance, January 1, 2021 | $ | ||||
Charge-offs | ( | ||||
Balance, March 31, 2021 | $ | ||||
Balance at January 1, 2020 | $ | ||||
Additions for which credit losses were not previously recognized | |||||
Balance at March 31, 2020 | $ |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Gross realized investment gains | $ | $ | |||||||||
Gross realized investment losses | — | ( | |||||||||
Credit losses | — | ( | |||||||||
Total | $ | $ | ( |
Amortized Cost | Fair Value | ||||||||||
(in millions) | |||||||||||
Due within one year | $ | $ | |||||||||
Due after one year through five years | |||||||||||
Due after five years through 10 years | |||||||||||
Due after 10 years | |||||||||||
Residential mortgage backed securities | |||||||||||
Commercial mortgage backed securities | |||||||||||
Asset backed securities | |||||||||||
Total | $ | $ |
The following is a summary of net investment income: | Three Months Ended March 31, | ||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Fixed maturities | $ | $ | |||||||||
Mortgage loans | |||||||||||
Other investments | ( | ||||||||||
Less: investment expenses | |||||||||||
Total | $ | $ |
Commercial Loans | |||||
(in millions) | |||||
Balance, January 1, 2021 | $ | ||||
Provisions | ( | ||||
Balance, March 31, 2021 | $ |
Commercial Loans | |||||
(in millions) | |||||
Balance, December 31, 2019 (1) | $ | ||||
Cumulative effect of adoption of current expected credit losses guidance | |||||
Balance, January 1, 2020 | |||||
Provisions | |||||
Balance, March 31, 2020 | $ |
March 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio | 2021 | 2020 | 2019 | 2018 | 2017 | Prior | Total | |||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
> 100% | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||||
80% - 100% | ||||||||||||||||||||||||||||||||||||||||||||
60% - 80% | ||||||||||||||||||||||||||||||||||||||||||||
40% - 60% | ||||||||||||||||||||||||||||||||||||||||||||
< 40% | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ |
December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
Loan-to-Value Ratio | 2020 | 2019 | 2018 | 2017 | 2016 | Prior | Total | |||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
> 100% | $ | — | $ | — | $ | $ | — | $ | — | $ | $ | |||||||||||||||||||||||||||||||||
80% - 100% | ||||||||||||||||||||||||||||||||||||||||||||
60% - 80% | ||||||||||||||||||||||||||||||||||||||||||||
40% - 60% | ||||||||||||||||||||||||||||||||||||||||||||
< 40% | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ |
Loans | Percentage | ||||||||||||||||||||||
March 31, 2021 | December 31, 2020 | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
South Atlantic | $ | $ | % | % | |||||||||||||||||||
Pacific | |||||||||||||||||||||||
Mountain | |||||||||||||||||||||||
West North Central | |||||||||||||||||||||||
East North Central | |||||||||||||||||||||||
Middle Atlantic | |||||||||||||||||||||||
West South Central | |||||||||||||||||||||||
New England | |||||||||||||||||||||||
East South Central | |||||||||||||||||||||||
% | % | ||||||||||||||||||||||
Less: allowance for loan losses | |||||||||||||||||||||||
Total | $ | $ |
Loans | Percentage | ||||||||||||||||||||||
March 31, 2021 | December 31, 2020 | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Retail | $ | $ | % | % | |||||||||||||||||||
Office | |||||||||||||||||||||||
Apartments | |||||||||||||||||||||||
Industrial | |||||||||||||||||||||||
Mixed use | |||||||||||||||||||||||
Hotel | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
% | % | ||||||||||||||||||||||
Less: allowance for loan losses | |||||||||||||||||||||||
Total | $ | $ |
March 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||
Internal Risk Rating | 2021 | 2020 | 2019 | 2018 | 2017 | Prior | Total | |||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Risk 5 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | $ | ||||||||||||||||||||||||||||||||
Risk 4 | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Risk 3 | — | |||||||||||||||||||||||||||||||||||||||||||
Risk 2 | ||||||||||||||||||||||||||||||||||||||||||||
Risk 1 | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ |
December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||
Internal Risk Rating | 2020 | 2019 | 2018 | 2017 | 2016 | Prior | Total | |||||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||||||||||||
Risk 5 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | $ | ||||||||||||||||||||||||||||||||
Risk 4 | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Risk 3 | — | |||||||||||||||||||||||||||||||||||||||||||
Risk 2 | ||||||||||||||||||||||||||||||||||||||||||||
Risk 1 | ||||||||||||||||||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ |
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Balance at January 1 | $ | $ | |||||||||
Capitalization of acquisition costs | |||||||||||
Amortization | ( | ( | |||||||||
Impact of change in net unrealized (gains) losses on securities | |||||||||||
Balance at March 31 | $ | $ |
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Balance at January 1 | $ | $ | |||||||||
Amortization | ( | ( | |||||||||
Impact of change in net unrealized (gains) losses on securities | |||||||||||
Balance at March 31 | $ | $ |
March 31, 2021 | December 31, 2020 | ||||||||||
(in millions) | |||||||||||
Policyholder account balances | |||||||||||
Fixed annuities (1) | $ | $ | |||||||||
Variable annuity fixed sub-accounts | |||||||||||
Universal life (“UL”)/variable universal life (“VUL”) insurance | |||||||||||
Indexed universal life (“IUL”) insurance | |||||||||||
Structured variable annuities | |||||||||||
Other life insurance | |||||||||||
Total policyholder account balances | |||||||||||
Future policy benefits | |||||||||||
Variable annuity guaranteed minimum withdrawal benefits (“GMWB”) | |||||||||||
Variable annuity guaranteed minimum accumulation benefits (“GMAB”) (2) | ( | ||||||||||
Other annuity liabilities | |||||||||||
Fixed annuity life contingent liabilities | |||||||||||
Life and disability income insurance | |||||||||||
Long term care insurance | |||||||||||
UL/VUL and other life insurance additional liabilities | |||||||||||
Total future policy benefits | |||||||||||
Policy claims and other policyholders’ funds | |||||||||||
Total policyholder account balances, future policy benefits and claims | $ | $ |
March 31, 2021 | December 31, 2020 | ||||||||||
(in millions) | |||||||||||
Variable annuity | $ | $ | |||||||||
VUL insurance | |||||||||||
Other insurance | |||||||||||
Total | $ | $ |
Variable Annuity Guarantees by Benefit Type (1) | March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||||||||||
Total Contract Value | Contract Value in Separate Accounts | Net Amount at Risk | Weighted Average Attained Age | Total Contract Value | Contract Value in Separate Accounts | Net Amount at Risk | Weighted Average Attained Age | |||||||||||||||||||||||||||||||||||||||||||
(in millions, except age) | ||||||||||||||||||||||||||||||||||||||||||||||||||
GMDB: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Return of premium | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
Five/six-year reset | ||||||||||||||||||||||||||||||||||||||||||||||||||
One-year ratchet | ||||||||||||||||||||||||||||||||||||||||||||||||||
Five-year ratchet | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total — GMDB | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
GGU death benefit | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
GMIB | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
GMWB: | ||||||||||||||||||||||||||||||||||||||||||||||||||
GMWB | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
GMWB for life | ||||||||||||||||||||||||||||||||||||||||||||||||||
Total — GMWB | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
GMAB | $ | $ | $ | $ | $ | $ |
March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||
Net Amount at Risk | Weighted Average Attained Age | Net Amount at Risk | Weighted Average Attained Age | ||||||||||||||||||||
(in millions, except age) | |||||||||||||||||||||||
UL secondary guarantees | $ | $ |
GMDB & GGU | GMIB | GMWB (1) | GMAB (1) | UL | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance at January 1, 2020 | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||
Incurred claims | |||||||||||||||||||||||||||||
Paid claims | ( | — | — | — | ( | ||||||||||||||||||||||||
Balance at March 31, 2020 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Balance at January 1, 2021 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Incurred claims | ( | ( | |||||||||||||||||||||||||||
Paid claims | ( | — | — | — | ( | ||||||||||||||||||||||||
Balance at March 31, 2021 | $ | $ | $ | $ | ( | $ |
March 31, 2021 | December 31, 2020 | ||||||||||
(in millions) | |||||||||||
Mutual funds: | |||||||||||
Equity | $ | $ | |||||||||
Bond | |||||||||||
Other | |||||||||||
Total mutual funds | $ | $ |
March 31, 2021 | ||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Available-for-Sale securities: | ||||||||||||||||||||||||||
Corporate debt securities | $ | — | $ | $ | $ | |||||||||||||||||||||
Residential mortgage backed securities | — | |||||||||||||||||||||||||
Commercial mortgage backed securities | — | — | ||||||||||||||||||||||||
State and municipal obligations | — | — | ||||||||||||||||||||||||
Asset backed securities | — | |||||||||||||||||||||||||
Foreign government bonds and obligations | — | — | ||||||||||||||||||||||||
Total Available-for-Sale securities | — | |||||||||||||||||||||||||
Cash equivalents | — | |||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||
Interest rate derivative contracts | — | — | ||||||||||||||||||||||||
Equity derivative contracts | — | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | |||||||||||||||||||||||||
Credit derivative contracts | — | — | ||||||||||||||||||||||||
Total other assets | — | |||||||||||||||||||||||||
Separate account assets at net asset value (“NAV”) | (1) | |||||||||||||||||||||||||
Total assets at fair value | $ | $ | $ | $ |
Liabilities | ||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims: | ||||||||||||||||||||||||||
Fixed deferred indexed annuity embedded derivatives | $ | — | $ | $ | $ | |||||||||||||||||||||
IUL embedded derivatives | — | — | ||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | — | — | (2) | |||||||||||||||||||||||
Structured variable annuity embedded derivatives | — | — | ||||||||||||||||||||||||
Total policyholder account balances, future policy benefits and claims | — | (3) | ||||||||||||||||||||||||
Other liabilities: | ||||||||||||||||||||||||||
Interest rate derivative contracts | — | |||||||||||||||||||||||||
Equity derivative contracts | — | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | — | ||||||||||||||||||||||||
Total other liabilities | — | |||||||||||||||||||||||||
Total liabilities at fair value | $ | $ | $ | $ |
December 31, 2020 | ||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Available-for-Sale securities: | ||||||||||||||||||||||||||
Corporate debt securities | $ | — | $ | $ | $ | |||||||||||||||||||||
Residential mortgage backed securities | — | |||||||||||||||||||||||||
Commercial mortgage backed securities | — | — | ||||||||||||||||||||||||
State and municipal obligations | — | — | ||||||||||||||||||||||||
Asset backed securities | — | |||||||||||||||||||||||||
Foreign government bonds and obligations | — | — | ||||||||||||||||||||||||
U.S. government and agency obligations | — | — | ||||||||||||||||||||||||
Total Available-for-Sale securities | ||||||||||||||||||||||||||
Cash equivalents | — | |||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||
Interest rate derivative contracts | — | |||||||||||||||||||||||||
Equity derivative contracts | — | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | |||||||||||||||||||||||||
Credit derivative contracts | — | — | ||||||||||||||||||||||||
Total other assets | — | |||||||||||||||||||||||||
Separate account assets at NAV | (1) | |||||||||||||||||||||||||
Total assets at fair value | $ | $ | $ | $ |
Liabilities | ||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims: | ||||||||||||||||||||||||||
Fixed deferred indexed annuity embedded derivatives | $ | — | $ | $ | $ | |||||||||||||||||||||
IUL embedded derivatives | — | — | ||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | — | — | (4) | |||||||||||||||||||||||
Structured variable annuity embedded derivatives | — | — | ||||||||||||||||||||||||
Total policyholder account balances, future policy benefits and claims | — | (5) | ||||||||||||||||||||||||
Other liabilities: | ||||||||||||||||||||||||||
Interest rate derivative contracts | — | — | ||||||||||||||||||||||||
Equity derivative contracts | — | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | — | ||||||||||||||||||||||||
Credit derivative contracts | — | — | ||||||||||||||||||||||||
Total other liabilities | — | |||||||||||||||||||||||||
Total liabilities at fair value | $ | $ | $ | $ |
Available-for-Sale Securities | |||||||||||||||||||||||
Corporate Debt Securities | Residential Mortgage Backed Securities | Asset Backed Securities | Total | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Balance, January 1, 2021 | $ | $ | $ | $ | |||||||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | |||||||||||||||||||||
Purchases | — | — | |||||||||||||||||||||
Settlements | — | — | ( | ( | |||||||||||||||||||
Balance, March 31, 2021 | $ | $ | $ | $ | |||||||||||||||||||
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at March 31, 2021 | $ | ( | $ | — | $ | $ | ( |
Policyholder Account Balances, Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
Fixed Deferred Indexed Annuity Embedded Derivatives | IUL Embedded Derivatives | GMWB and GMAB Embedded Derivatives | Structured Variable Annuity Embedded Derivatives | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2021 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Total (gains) losses included in: | |||||||||||||||||||||||||||||
Net income | (1) | (1) | ( | (2) | (2) | ( | |||||||||||||||||||||||
Issues | — | ( | |||||||||||||||||||||||||||
Settlements | ( | ( | ( | ||||||||||||||||||||||||||
Balance, March 31, 2021 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Changes in unrealized (gains) losses in net income relating to liabilities held at March 31, 2021 | $ | — | $ | (1) | $ | ( | (2) | $ | — | $ | ( |
Available-for-Sale Securities | |||||||||||||||||||||||
Corporate Debt Securities | Residential Mortgage Backed Securities | Asset Backed Securities | Total | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Balance, January 1, 2020 | $ | $ | $ | $ | |||||||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||
Other comprehensive income (loss) | ( | ( | ( | ||||||||||||||||||||
Purchases | — | — | |||||||||||||||||||||
Settlements | ( | — | — | ( | |||||||||||||||||||
Balance, March 31, 2020 | $ | $ | $ | $ | |||||||||||||||||||
Changes in unrealized gains (losses) in other comprehensive income (loss) relating to assets held at March 31, 2020 | $ | ( | $ | — | $ | ( | $ | ( |
Policyholder Account Balances, Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
Fixed Deferred Indexed Annuity Embedded Derivatives | IUL Embedded Derivatives | GMWB and GMAB Embedded Derivatives | Structured Variable Annuity Embedded Derivatives | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2020 | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Total (gains) losses included in: | |||||||||||||||||||||||||||||
Net income | ( | (1) | ( | (1) | (2) | ( | (2) | ||||||||||||||||||||||
Issues | ( | ||||||||||||||||||||||||||||
Settlements | — | ( | — | ( | |||||||||||||||||||||||||
Balance, March 31, 2020 | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||
Changes in unrealized (gains) losses in net income relating to liabilities held at March 31, 2020 | $ | — | $ | ( | (1) | $ | (2) | $ | — | $ |
March 31, 2021 | |||||||||||||||||||||||||||||
Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Corporate debt securities (private placements) | $ | Discounted cash flow | Yield/spread to U.S. Treasuries (1) | – | |||||||||||||||||||||||||
Asset backed securities | $ | Discounted cash flow | Annual default rate | ||||||||||||||||||||||||||
Loss severity | |||||||||||||||||||||||||||||
Yield/spread to swap rates (2) | – | ||||||||||||||||||||||||||||
IUL embedded derivatives | $ | Discounted cash flow | Nonperformance risk (3) | ||||||||||||||||||||||||||
Fixed deferred indexed annuity embedded derivatives | $ | Discounted cash flow | Surrender rate (4) | – | |||||||||||||||||||||||||
Nonperformance risk (3) | |||||||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | $ | Discounted cash flow | Utilization of guaranteed withdrawals (5) (6) | – | |||||||||||||||||||||||||
Surrender rate (4) | – | ||||||||||||||||||||||||||||
Market volatility (7) (8) | – | ||||||||||||||||||||||||||||
Nonperformance risk (3) | |||||||||||||||||||||||||||||
Structured variable annuity embedded derivatives | $ | Discounted cash flow | Surrender rate (4) | – | |||||||||||||||||||||||||
Nonperformance risk (3) |
December 31, 2020 | |||||||||||||||||||||||||||||
Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Corporate debt securities (private placements) | $ | Discounted cash flow | Yield/spread to U.S. Treasuries (1) | – | |||||||||||||||||||||||||
Asset backed securities | $ | Discounted cash flow | Annual default rate | ||||||||||||||||||||||||||
Loss severity | |||||||||||||||||||||||||||||
Yield/spread to swap rates (2) | – | ||||||||||||||||||||||||||||
IUL embedded derivatives | $ | Discounted cash flow | Nonperformance risk (3) | ||||||||||||||||||||||||||
Fixed deferred indexed annuity embedded derivatives | $ | Discounted cash flow | Surrender rate (4) | – | |||||||||||||||||||||||||
Nonperformance risk (3) | |||||||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | $ | Discounted cash flow | Utilization of guaranteed withdrawals (5) (6) | – | |||||||||||||||||||||||||
Surrender rate (4) | – | ||||||||||||||||||||||||||||
Market volatility (7) (8) | – | ||||||||||||||||||||||||||||
Nonperformance risk (3) | |||||||||||||||||||||||||||||
Structured variable annuity embedded derivatives | $ | Discounted cash flow | Surrender rate (4) | – | |||||||||||||||||||||||||
Nonperformance risk (3) |
March 31, 2021 | |||||||||||||||||||||||||||||
Carrying Value | Fair Value | ||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Financial Assets | |||||||||||||||||||||||||||||
Mortgage loans, net | $ | $ | — | $ | — | $ | $ | ||||||||||||||||||||||
Policy loans | — | — | |||||||||||||||||||||||||||
Other investments | — | ||||||||||||||||||||||||||||
Other receivables | — | — | |||||||||||||||||||||||||||
Financial Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims | $ | $ | — | $ | — | $ | $ | ||||||||||||||||||||||
Short-term borrowings | — | — | |||||||||||||||||||||||||||
Long-term debt | — | — | |||||||||||||||||||||||||||
Other liabilities | — | — | |||||||||||||||||||||||||||
Separate account liabilities — investment contracts | — | — |
December 31, 2020 | |||||||||||||||||||||||||||||
Carrying Value | Fair Value | ||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Financial Assets | |||||||||||||||||||||||||||||
Mortgage loans, net | $ | $ | — | $ | — | $ | $ | ||||||||||||||||||||||
Policy loans | — | — | |||||||||||||||||||||||||||
Other investments | — | ||||||||||||||||||||||||||||
Other receivables | — | — | |||||||||||||||||||||||||||
Financial Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims | $ | $ | — | $ | — | $ | $ | ||||||||||||||||||||||
Short-term borrowings | — | — | |||||||||||||||||||||||||||
Long-term debt | — | — | |||||||||||||||||||||||||||
Other liabilities | — | — | |||||||||||||||||||||||||||
Separate account liabilities — investment contracts | — | — |
March 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | |||||||||||||||||||||||||||||||||||||
Financial Instruments (1) | Cash Collateral | Securities Collateral | |||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||||||||||
OTC | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
OTC cleared | — | ( | — | — | |||||||||||||||||||||||||||||||||||||
Exchange-traded | — | ( | ( | — | |||||||||||||||||||||||||||||||||||||
Total derivatives | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ |
December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | |||||||||||||||||||||||||||||||||||||
Financial Instruments (1) | Cash Collateral | Securities Collateral | |||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||||||||||
OTC | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
OTC cleared | — | ( | — | — | |||||||||||||||||||||||||||||||||||||
Exchange-traded | — | ( | ( | — | |||||||||||||||||||||||||||||||||||||
Total derivatives | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ |
March 31, 2021 | |||||||||||||||||||||||||||||||||||||||||
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | |||||||||||||||||||||||||||||||||||||
Financial Instruments (1) | Cash Collateral | Securities Collateral | |||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||||||||||
OTC | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
OTC cleared | — | ( | — | — | |||||||||||||||||||||||||||||||||||||
Exchange-traded | — | ( | — | — | |||||||||||||||||||||||||||||||||||||
Total derivatives | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ |
December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset in the Consolidated Balance Sheets | Net Amount | |||||||||||||||||||||||||||||||||||||
Financial Instruments (1) | Cash Collateral | Securities Collateral | |||||||||||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||||||||||||||
OTC | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||
OTC cleared | — | ( | — | — | |||||||||||||||||||||||||||||||||||||
Exchange-traded | — | ( | — | — | |||||||||||||||||||||||||||||||||||||
Total derivatives | $ | $ | — | $ | $ | ( | $ | ( | $ | ( | $ |
March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||
Notional | Gross Fair Value | Notional | Gross Fair Value | ||||||||||||||||||||
Assets (1) | Liabilities (2)(3) | Assets (1) | Liabilities (2)(3) | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Derivatives not designated as hedging instruments | |||||||||||||||||||||||
Interest rate contracts | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Equity contracts | |||||||||||||||||||||||
Credit contracts | — | ||||||||||||||||||||||
Foreign exchange contracts | |||||||||||||||||||||||
Total non-designated hedges | |||||||||||||||||||||||
Embedded derivatives | |||||||||||||||||||||||
GMWB and GMAB (4) | N/A | — | N/A | — | |||||||||||||||||||
IUL | N/A | — | N/A | — | |||||||||||||||||||
Fixed deferred indexed annuities | N/A | — | N/A | — | |||||||||||||||||||
Structured variable annuities | N/A | — | N/A | — | |||||||||||||||||||
Total embedded derivatives | N/A | — | N/A | — | |||||||||||||||||||
Total derivatives | $ | $ | $ | $ | $ | $ |
Net Investment Income | Interest Credited to Fixed Accounts | Benefits, Claims, Losses and Settlement Expenses | |||||||||||||||
(in millions) | |||||||||||||||||
Three Months Ended March 31, 2021 | |||||||||||||||||
Interest rate contracts | $ | — | $ | — | $ | ( | |||||||||||
Equity contracts | ( | ||||||||||||||||
Credit contracts | — | — | |||||||||||||||
Foreign exchange contracts | — | — | |||||||||||||||
GMWB and GMAB embedded derivatives | — | — | |||||||||||||||
IUL embedded derivatives | — | ( | — | ||||||||||||||
Fixed deferred indexed annuity embedded derivatives | — | ( | — | ||||||||||||||
Structured variable annuity embedded derivatives | — | — | ( | ||||||||||||||
Total gain (loss) | $ | $ | $ | ( | |||||||||||||
Interest Credited to Fixed Accounts | Benefits, Claims, Losses and Settlement Expenses | ||||||||||
(in millions) | |||||||||||
Three Months Ended March 31, 2020 | |||||||||||
Interest rate contracts | $ | — | $ | ||||||||
Equity contracts | ( | ||||||||||
Credit contracts | — | ( | |||||||||
Foreign exchange contracts | — | ||||||||||
GMWB and GMAB embedded derivatives | — | ( | |||||||||
IUL embedded derivatives | — | ||||||||||
Fixed deferred indexed annuity embedded derivatives | — | ||||||||||
Structured variable annuity embedded derivatives | — | ||||||||||
Total gain (loss) | $ | $ | |||||||||
Premiums Payable | Premiums Receivable | ||||||||||
(in millions) | |||||||||||
2021 (1) | $ | $ | |||||||||
2022 | |||||||||||
2023 | |||||||||||
2024 | |||||||||||
2025 | |||||||||||
2026 - 2028 | |||||||||||
Total | $ | $ |
Three Months Ended March 31, | |||||||||||||||||||||||||||||||||||
2021 | 2020 | ||||||||||||||||||||||||||||||||||
Pretax | Income Tax Benefit (Expense) | Net of Tax | Pretax | Income Tax Benefit (Expense) | Net of Tax | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Net unrealized gains (losses) on securities: | |||||||||||||||||||||||||||||||||||
Net unrealized gains (losses) on securities arising during the period (1) | $ | ( | $ | $ | ( | $ | ( | $ | $ | ( | |||||||||||||||||||||||||
Reclassification of net (gains) losses on securities included in net income (2) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables | ( | ( | |||||||||||||||||||||||||||||||||
Net unrealized gains (losses) on securities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Total other comprehensive income (loss) | $ | ( | $ | $ | ( | $ | ( | $ | $ | ( |
Net Unrealized Gains (Losses) on Securities | Other | Total | |||||||||||||||
(in millions) | |||||||||||||||||
Balance, January 1, 2021 | $ | $ | ( | $ | |||||||||||||
OCI before reclassifications | ( | ( | |||||||||||||||
Amounts reclassified from AOCI | ( | ( | |||||||||||||||
Total OCI | ( | ( | |||||||||||||||
Balance, March 31, 2021 | $ | $ | ( | $ | |||||||||||||
Balance, January 1, 2020 | $ | $ | ( | $ | |||||||||||||
OCI before reclassifications | ( | ( | |||||||||||||||
Amounts reclassified from AOCI | ( | ( | |||||||||||||||
Total OCI | ( | ( | |||||||||||||||
Balance, March 31, 2020 | $ | $ | ( | $ |
Three Months Ended March 31, | Change | ||||||||||||||||||||||
2021 | 2020 | ||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Revenues | |||||||||||||||||||||||
Premiums | $ | 78 | $ | 93 | $ | (15) | (16) | % | |||||||||||||||
Net investment income | 247 | 223 | 24 | 11 | |||||||||||||||||||
Policy and contract charges | 547 | 551 | (4) | (1) | |||||||||||||||||||
Other revenues | 128 | 119 | 9 | 8 | |||||||||||||||||||
Net realized investment gains (losses) | 48 | (17) | 65 | NM | |||||||||||||||||||
Total revenues | 1,048 | 969 | 79 | 8 | |||||||||||||||||||
Benefits and expenses | |||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | 652 | (1,748) | 2,400 | NM | |||||||||||||||||||
Interest credited to fixed accounts | 159 | 91 | 68 | 75 | |||||||||||||||||||
Amortization of deferred acquisition costs | 2 | 503 | (501) | NM | |||||||||||||||||||
Interest and debt expense | 21 | — | 21 | — | |||||||||||||||||||
Other insurance and operating expenses | 194 | 163 | 31 | 19 | |||||||||||||||||||
Total benefits and expenses | 1,028 | (991) | 2,019 | NM | |||||||||||||||||||
Pretax income | 20 | 1,960 | (1,940) | (99) | |||||||||||||||||||
Income tax provision | 2 | 166 | (164) | (99) | |||||||||||||||||||
Net income | $ | 18 | $ | 1,794 | $ | (1,776) | (99) | ||||||||||||||||
NM Not Meaningful. |
Equity Price Decline 10% | Equity Price Exposure to Pretax Income | |||||||||||||||||||
Before Hedge Impact | Hedge Impact | Net Impact | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Asset-based fees and expenses | $ | (75) | $ | — | $ | (75) | ||||||||||||||
DAC and DSIC amortization (1) (2) | (40) | — | (40) | |||||||||||||||||
Variable annuities: | ||||||||||||||||||||
GMDB and GMIB (2) | (10) | — | (10) | |||||||||||||||||
GMWB (2) | (291) | 256 | (35) | |||||||||||||||||
GMAB | (17) | 17 | — | |||||||||||||||||
Structured variable annuities | 160 | (133) | 27 | |||||||||||||||||
DAC and DSIC amortization (3) | N/A | N/A | 5 | |||||||||||||||||
Total variable annuities | (158) | 140 | (13) | |||||||||||||||||
Macro hedge program (4) | — | 219 | 219 | |||||||||||||||||
Fixed deferred indexed annuities | 6 | (4) | 2 | |||||||||||||||||
IUL insurance | 45 | (42) | 3 | |||||||||||||||||
Total | $ | (222) | $ | 313 | $ | 96 |
Interest Rate Increase 100 Basis Points | Interest Rate Exposure to Pretax Income | |||||||||||||||||||
Before Hedge Impact | Hedge Impact | Net Impact | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Asset-based fees and expenses | $ | (16) | $ | — | $ | (16) | ||||||||||||||
Variable annuities: | ||||||||||||||||||||
GMWB | 1,192 | (1,477) | (285) | |||||||||||||||||
GMAB | 19 | (25) | (6) | |||||||||||||||||
Structured variable annuities | (12) | 49 | 37 | |||||||||||||||||
DAC and DSIC amortization (3) | N/A | N/A | 42 | |||||||||||||||||
Total variable annuities | 1,199 | (1,453) | (212) | |||||||||||||||||
Macro hedge program (4) | — | (4) | (4) | |||||||||||||||||
Fixed deferred indexed annuities | (1) | — | (1) | |||||||||||||||||
Fixed annuities, fixed insurance and fixed portion of variable annuities and variable insurance products | 51 | — | 51 | |||||||||||||||||
IUL insurance | 17 | 1 | 18 | |||||||||||||||||
Total | $ | 1,250 | $ | (1,456) | $ | (164) |
Three Months Ended March 31, | |||||||||||
2021 | 2020 | ||||||||||
(in millions) | |||||||||||
Paid to Ameriprise Financial | $ | 250 | $ | 250 | |||||||
Actual Capital (1) | Regulatory Capital Requirements (2) | ||||||||||||||||
March 31, 2021 | December 31, 2020 | December 31, 2020 | |||||||||||||||
(in millions) | |||||||||||||||||
RiverSource Life Insurance Company | $ | 4,522 | $ | 5,021 | $ | 993 | |||||||||||
RiverSource Life Insurance Co. of NY | 240 | 323 | 42 |
Exhibit | Description | ||||
Copy of Certificate of Incorporation of IDS Life Insurance Company, filed as Exhibit 3.1 to Post-Effective Amendment No. 5 to Registration Statement No. 33-28976, is incorporated by reference. | |||||
Copy of Certificate of Amendment of Certificate of Incorporation of IDS Life Insurance Company dated June 22, 2006, filed as Exhibit 3.1 to Form 8-K filed on January 5, 2007, is incorporated by reference. | |||||
Copy of Amended and Restated By-Laws of RiverSource Life Insurance Company dated June 22, 2006, filed as Exhibit 27(f)(2) to Post-Effective Amendment No. 28 to Registration Statement No. 333-69777, is incorporated by reference. | |||||
31.1* | Certification of Gumer C. Alvero, Executive Vice President - Annuities (Acting Principal Executive Officer), pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended. | ||||
31.2* | Certification of Brian J. McGrane, Chief Financial Officer, pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended. | ||||
32* | Certification of Gumer C. Alvero, Executive Vice President - Annuities (Acting Principal Executive Officer) and Brian J. McGrane, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
101 | The following materials from RiverSource Life Insurance Company on Form 10-Q for the period ended March 31, 2021 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at March 31, 2021 and December 31, 2020; (ii) Consolidated Statements of Income for the three months ended March 31, 2021 and 2020; (iii) Consolidated Statements of Comprehensive Income for the three months ended March 31, 2021 and 2020; (iv) Consolidated Statements of Equity for the three months ended March 31, 2021 and 2020; (v) Consolidated Statements of Cash Flows for the three months ended March 31, 2021 and 2020; and (vi) Notes to the Consolidated Financial Statements. | ||||
104 | The cover page from RiverSource Life Insurance Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2021 is formatted in iXBRL and contained in Exhibit 101. | ||||
* Filed electronically herewithin. |
RIVERSOURCE LIFE INSURANCE COMPANY | |||||||||||
(Registrant) |
Date: | May 10, 2021 | By: | /s/ Brian J. McGrane | ||||||||
Brian J. McGrane Executive Vice President and Chief Financial Officer |
Date: | May 10, 2021 | By: | /s/ Gumer C. Alvero | ||||||||
Gumer C. Alvero Interim Chairman of the Board and Executive Vice President - Annuities (Principal Executive Officer) |
Date: | May 10, 2021 | By: | /s/ Brian J. McGrane | ||||||||
Brian J. McGrane Chief Financial Officer |
Date: | May 10, 2021 | By: | /s/ Gumer C. Alvero | ||||||||
Gumer C. Alvero Interim Chairman of the Board and Executive Vice President - Annuities (Principal Executive Officer) |
Date: | May 10, 2021 | By: | /s/ Brian J. McGrane | ||||||||
Brian J. McGrane Chief Financial Officer |
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Shareholder's equity: | ||
Common stock, par value (in dollars per share) | $ 30 | $ 30 |
Common stock, shares authorized (in shares) | 100,000 | 100,000 |
Common stock, shares issued (in shares) | 100,000 | 100,000 |
Common stock, shares outstanding (in shares) | 100,000 | 100,000 |
RiverSource Life | ||
Assets | ||
Fixed maturities, amortized cost | $ 20,153,000,000 | $ 20,260,000,000 |
Available-for-sale: Fixed maturities, allowance for credit losses | 0 | 10,000,000 |
Mortgage loans, allowance for loan losses | 28,000,000 | 28,000,000 |
Other Investments, Allowance for Credit Loss | 5,000,000 | 7,000,000 |
Reinsurance recoverables, allowance for credit loss | $ 9,000,000 | $ 8,000,000 |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Revenues | ||
Premiums | $ 78 | $ 93 |
Net investment income | 247 | 223 |
Policy and contract charges | 547 | 551 |
Other revenues | 128 | 119 |
Net realized investment gains (losses) | 48 | (17) |
Total revenues | 1,048 | 969 |
Benefits and expenses | ||
Benefits, claims, losses and settlement expenses | 652 | (1,748) |
Interest credited to fixed accounts | 159 | 91 |
Amortization of deferred acquisition costs | 2 | 503 |
Interest and Debt Expense | 21 | 0 |
Other insurance and operating expenses | 194 | 163 |
Total benefits and expenses | 1,028 | (991) |
Pretax income | 20 | 1,960 |
Income tax provision | 2 | 166 |
Net Income | $ 18 | $ 1,794 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Statement of Comprehensive Income [Abstract] | ||
Net Income | $ 18 | $ 1,794 |
Other comprehensive income (loss), net of tax: | ||
Net unrealized gains (losses) on securities | (338) | (395) |
Total other comprehensive income (loss), net of tax | (338) | (395) |
Total comprehensive income | $ (320) | $ 1,399 |
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) $ in Millions |
Total |
Common shares [Member] |
Additional paid-in capital [Member] |
Retained earnings [Member] |
Accumulated other comprehensive income (loss) [Member] |
Cumulative Effect, Period of Adoption, Adjustment [Member] |
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained earnings [Member]
|
---|---|---|---|---|---|---|---|
Beginning balance at Dec. 31, 2019 | $ 3,336 | $ 3 | $ 2,466 | $ 293 | $ 574 | ||
Beginning balance (Current expected credit losses guidance [Member]) at Dec. 31, 2019 | $ (7) | $ (7) | |||||
Comprehensive income: | |||||||
Net Income | 1,794 | 1,794 | |||||
Other comprehensive income (loss), net of tax | (395) | (395) | |||||
Total comprehensive income | 1,399 | ||||||
Cash dividends to Ameriprise Financial, Inc. | (250) | (250) | |||||
Ending balance at Mar. 31, 2020 | 4,478 | 3 | 2,466 | 1,830 | 179 | ||
Beginning balance at Dec. 31, 2020 | 3,313 | 3 | 2,466 | (76) | 920 | ||
Comprehensive income: | |||||||
Net Income | 18 | 18 | |||||
Other comprehensive income (loss), net of tax | (338) | (338) | |||||
Total comprehensive income | (320) | ||||||
Cash dividends to Ameriprise Financial, Inc. | (250) | (250) | |||||
Ending balance at Mar. 31, 2021 | $ 2,743 | $ 3 | $ 2,466 | $ (308) | $ 582 |
Basis of Presentation |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | RiverSource Life Insurance Company is a stock life insurance company with one wholly owned stock life insurance company subsidiary, RiverSource Life Insurance Co. of New York (“RiverSource Life of NY”). RiverSource Life Insurance Company is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”). •RiverSource Life Insurance Company is domiciled in Minnesota and holds Certificates of Authority in American Samoa, the District of Columbia and all states except New York. RiverSource Life Insurance Company issues insurance and annuity products. •RiverSource Life of NY is domiciled and holds a Certificate of Authority in New York. RiverSource Life of NY issues insurance and annuity products. RiverSource Life Insurance Company also wholly owns RiverSource Tax Advantaged Investments, Inc. (“RTA”). RTA is a stock company domiciled in Delaware and is a limited partner in affordable housing partnership investments. The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest and variable interest entities (“VIEs”) in which it is the primary beneficiary (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation. The interim financial information in this report has not been audited. In the opinion of management, all adjustments necessary for fair statement of the consolidated financial position and results of operations for the interim periods have been made. All adjustments made were of a normal recurring nature. The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. These Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission on February 24, 2021 (“2020 10-K”). The Company evaluated events or transactions that may have occurred after the balance sheet date for potential recognition or disclosure through the date the financial statements were issued. No subsequent events or transactions requiring recognition or disclosure were identified.
|
Recent Accounting Pronouncements |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
Recent Accounting Pronouncements | Adoption of New Accounting Standards Income Taxes – Simplifying the Accounting for Income Taxes In December 2019, the Financial Accounting Standards Board (“FASB”) updated the accounting standards to simplify the accounting for income taxes. The update eliminates certain exceptions to: (1) accounting principles related to intra-period tax allocation to be applied on a prospective basis, (2) deferred tax liabilities related to outside basis differences to be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption, and (3) year-to-date losses in interim periods to be applied on a prospective basis. The update also amends existing guidance related to situations when an entity receives: (1) a step-up in the tax basis of goodwill to be applied on a prospective basis, (2) an allocation of income tax expense when members of a consolidated tax filing group issue separate financial statements to be applied on a retrospective basis for all periods presented, (3) interim recognition of enactment of tax laws or rate changes to be applied on a prospective basis, and (4) franchise taxes and other taxes partially based on income to be applied on a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. The standard is effective for interim and annual periods beginning after December 15, 2020, with early adoption permitted. The Company adopted the standard on January 1, 2021. The adoption of this standard had no impact on the Company’s consolidated financial condition or results of operations. Fair Value Measurement – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement In August 2018, the FASB updated the accounting standards related to disclosures for fair value measurements. The update eliminates the following disclosures: (1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (2) the policy of timing of transfers between levels of the fair value hierarchy, and (3) the valuation processes for Level 3 fair value measurements. The new disclosures include changes in unrealized gains and losses for the period included in OCI for recurring Level 3 fair value measurements of instruments held at the end of the reporting period and the range and weighted average used to develop significant unobservable inputs and how the weighted average was calculated. The new disclosures are required on a prospective basis; all other provisions should be applied retrospectively. The update is effective for interim and annual periods beginning after December 15, 2019. Early adoption is permitted for the entire standard or only the provisions to eliminate or modify disclosure requirements. The Company early adopted the provisions of the standard to eliminate or modify disclosure requirements in the fourth quarter of 2018. The Company adopted the provisions of the standard to include new disclosures on January 1, 2020. The update did not have an impact on the Company’s consolidated financial condition or results of operations. Intangibles – Goodwill and Other – Internal-Use Software – Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract In August 2018, the FASB updated the accounting standards related to customer’s accounting for implementation costs incurred in a cloud computing arrangement (“CCA”) that is a service contract. The update requires implementation costs for a CCA to be evaluated for capitalization using the same approach as implementation costs associated with internal-use software. The update also addresses presentation, measurement and impairment of capitalized implementation costs in a CCA that is a service contract. The update requires new disclosures on the nature of hosting arrangements that are service contracts, significant judgements made when applying the guidance and quantitative disclosures, including amounts capitalized, amortized and impaired. The update is effective for interim and annual periods beginning after December 15, 2019, and can be applied either prospectively or retrospectively. The Company adopted the standard using a prospective approach on January 1, 2020. The adoption did not have an impact on the Company’s consolidated financial condition or results of operations. Financial Instruments – Credit Losses – Measurement of Credit Losses on Financial Instruments In June 2016, the FASB updated the accounting standards related to accounting for credit losses on certain types of financial instruments. The update replaces the current incurred loss model for estimating credit losses with a new model that requires an entity to estimate the credit losses expected over the life of the asset. At adoption, the initial estimate of the expected credit losses will be recorded through retained earnings and subsequent changes in the estimate will be reported in current period earnings and recorded through an allowance for credit losses on the balance sheet. The credit loss model for Available-for-Sale debt securities did not change; however, the credit loss calculation and subsequent recoveries are required to be recorded through an allowance. The standard is effective for interim and annual periods beginning after December 15, 2019. A modified retrospective cumulative adjustment to retained earnings should be recorded as of the first reporting period in which the guidance is effective for loans, receivables, and other financial instruments subject to the new expected credit loss model. Prospective adoption is required for establishing an allowance related to Available-for-Sale debt securities, certain beneficial interests, and financial assets purchased with a more-than-insignificant amount of credit deterioration since origination. The Company adopted the standard on January 1, 2020. The adoption of this update did not have a material impact on the Company’s consolidated financial condition or results of operations. Future Adoption of New Accounting Standards Reference Rate Reform – Expedients for Contract Modifications In March 2020, the FASB updated the accounting standards to provide optional expedients and exceptions for applying GAAP to contracts, hedging or other transactions that are affected by reference rate reform (i.e., the elimination of LIBOR). The following expedients are provided for modified contracts whose reference rate is changed: (1) receivables and debt contracts are accounted for prospectively by adjusting the effective interest rate, (2) leases are accounted for as a continuation of the existing contracts with no reassessments of the lease classification and discount rate or remeasurements of lease payments that otherwise would be required, and (3) an entity is not required to reassess its original conclusion about whether that contract contains an embedded derivative that is clearly and closely related to the economic characteristics and risks of the host contract. The amendments in this update were effective upon issuance and must be elected prior to December 31, 2022. When elected, the optional expedients for contract modifications must be applied consistently for all eligible contracts or eligible transactions. In January 2021, FASB updated the standard to allow an entity to elect to apply the treatment under the original guidance to derivative instruments that use an interest rate that for margining, discounting or contract price alignment that will be modified due to reference rate reform but did not qualify under the original guidance. The Company has not yet applied any of the optional expedients. The adoption of the standard is not expected to have an impact on the Company’s consolidated results of operations and financial condition.
|
Revenue from Contracts with Customers |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contracts with Customers [Text Block] | The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Consolidated Statements of Income.
(1) Amounts primarily consist of revenue associated with insurance and annuity products or financial instruments. The following discussion describes the nature, timing, and uncertainty of revenues and cash flows arising from the Company’s contracts with customers. Policy and contract charges The Company earns revenue for providing distribution-related services to affiliated and unaffiliated mutual funds that are available as underlying investments in its variable annuity and variable life insurance products. The performance obligation is satisfied at the time the mutual fund is distributed. Revenue is recognized over the time the mutual fund is held in the variable product and is generally earned based on a fixed rate applied, as a percentage, to the net asset value of the fund. The revenue is not recognized at the time of sale because it is variably constrained due to factors outside the Company’s control, including market volatility and how long the fund(s) remain in the insurance policy or annuity contract. The revenue will not be recognized until it is probable that a significant reversal will not occur. These fees are accrued and collected on a monthly basis. Other revenues Administrative fees The Company earns revenue for providing customer support, contract servicing and administrative services for affiliated and unaffiliated mutual funds that are available as underlying instruments in its variable annuity and variable life insurance products. The transfer agent and administration revenue is earned daily based on a fixed rate applied, as a percentage, to assets under management. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis. Other fees The Company earns revenue for providing affiliated and unaffiliated partners an opportunity to educate the financial advisors of its affiliate, Ameriprise Financial Services, LLC, that sell the Company's products as well as product and marketing personnel to support the offer, sale and servicing of funds within the Company's variable annuity and variable life insurance products. These payments allow the parties to train and support the advisors, explain the features of their products, and distribute marketing and educational materials. The affiliated revenue is earned based on a rate, updated at least annually, which is applied, as a percentage, to the market value of assets invested. The unaffiliated revenue is earned based on a fixed rate applied, as a percentage, to the market value of assets invested. These performance obligations are considered a series of distinct services that are substantially the same and are satisfied each day over the contract term. These fees are accrued and collected on a monthly basis. Receivables Receivables for revenue from contracts with customers are recognized when the performance obligation is satisfied and the Company has an unconditional right to the revenue. Receivables related to revenues from contracts with customers were $59 million and $57 million as of March 31, 2021 and December 31, 2020, respectively.
|
Variable Interest Entities Variable Interest Entities |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Variable Interest Entity, Not Primary Beneficiary, Disclosures [Abstract] | |
Variable Interest Entities [Text Block] | Variable Interest Entities The Company provides asset management services to collateralized loan obligations (“CLOs”) which are considered to be VIEs that are sponsored by the Company. In addition, the Company invests in structured investments other than CLOs and certain affordable housing partnerships which are considered VIEs. The Company consolidates the CLOs if the Company is deemed to be the primary beneficiary. The Company has no obligation to provide financial or other support to the non-consolidated VIEs beyond its initial investment and existing future funding commitments, and the Company has not provided any support to these entities. The Company has unfunded commitments related to consolidated CLOs of $20 million and $13 million as of March 31, 2021 and December 31, 2020, respectively. CLOs CLOs are asset backed financing entities collateralized by a pool of assets, primarily syndicated loans and, to a lesser extent, high-yield bonds. Multiple tranches of debt securities are issued by a CLO, offering investors various maturity and credit risk characteristics. The debt securities issued by the CLOs are non-recourse to the Company. The CLO’s debt holders have recourse only to the assets of the CLO. The assets of the CLOs cannot be used by the Company. Scheduled debt payments are based on the performance of the CLO’s collateral pool. The Company earns management fees from the CLOs based on the value of the CLO’s collateral pool and, in certain instances, may also receive incentive fees. The fee arrangement is at market and commensurate with the level of effort required to provide those services. The Company has invested in a portion of the unrated, junior subordinated notes and highly rated senior notes of certain CLOs. The Company consolidates certain CLOs where it is the primary beneficiary and has the power to direct the activities that most significantly impact the economic performance of the CLO. Affordable Housing Partnerships and Other Real Estate Partnerships The Company is a limited partner in affordable housing partnerships that qualify for government-sponsored low income housing tax credit programs and partnerships that invest in multi-family residential properties that were originally developed with an affordable housing component. The Company has determined it is not the primary beneficiary and therefore does not consolidate these partnerships. A majority of the limited partnerships are variable interest entities (“VIEs”). The Company’s maximum exposure to loss as a result of its investment in the VIEs is limited to the carrying value. The carrying value is reflected in other investments and was $187 million and $200 million as of March 31, 2021 and December 31, 2020, respectively. The Company had a $9 million liability recorded as of both March 31, 2021 and December 31, 2020 related to original purchase commitments not yet remitted to the VIEs. The Company has not provided any additional support and is not contractually obligated to provide additional support to the VIEs beyond the funding commitments. Structured Investments The Company invests in structured investments which are considered VIEs for which it is not the sponsor. These structured investments typically invest in fixed income instruments and are managed by third parties and include asset backed securities, commercial and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the size of the Company’s investment in the entities and position in the capital structure of these entities. The Company’s maximum exposure to loss as a result of its investment in these structured investments is limited to its amortized cost. See Note 5 for additional information on these structured investments.
|
Investments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments [Text Block] | Available-for-Sale securities distributed by type were as follows:
In March 2020, the Company purchased $368 million of investments at fair value, primarily agency residential mortgage back securities, from Ameriprise Financial. As of March 31, 2021 and December 31, 2020, accrued interest of $135 million and $158 million, respectively, is excluded from the amortized cost basis of Available-for-Sale securities in the tables above and is recorded in accrued investment income on the Consolidated Balance Sheets. As of March 31, 2021 and December 31, 2020, investment securities with a fair value of $2.7 billion and $2.9 billion, respectively, were pledged to meet contractual obligations under derivative contracts and short-term borrowings, of which $417 million and $454 million, respectively, may be sold, pledged or rehypothecated by the counterparty. As of both March 31, 2021 and December 31, 2020, fixed maturity securities comprised approximately 85% of the Company’s total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of March 31, 2021 and December 31, 2020, approximately $516 million and $553 million, respectively, of securities were internally rated by Columbia Management Investment Advisers, LLC, an affiliate of the Company, using criteria similar to those used by NRSROs. A summary of fixed maturity securities by rating was as follows:
As of March 31, 2021 and December 31, 2020, approximately 36% and 37%, respectively, of securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities. The Company had holdings of $356 million in Ameriprise Advisor Financing, LLC (“AAF”), an affiliate of the Company, which was greater than 10% of total equity as of March 31, 2021. The Company had holdings of $372 million in AAF, which was greater than 10% of total equity as of December 31, 2020. There were no other holdings of any other issuer greater than 10% of total equity as of both March 31, 2021 and December 31, 2020. The following tables summarize the fair value and gross unrealized losses on Available-for-Sale securities, aggregated by major investment type and the length of time that individual securities have been in a continuous unrealized loss position for which no allowance for credit losses has been recorded:
As part of the Company’s ongoing monitoring process, management determined that the change in gross unrealized losses on its Available-for-Sale securities for which an allowance for credit losses has not been recognized during the three months ended March 31, 2021 is primarily attributable to higher interest rates, partially offset by tighter credit spreads. The Company did not recognize these unrealized losses in earnings because it was determined that such losses were due to non-credit factors. The Company does not intend to sell these securities and does not believe that it is more likely than not that the Company will be required to sell these securities before the anticipated recovery of the remaining amortized cost basis. As of March 31, 2021 and December 31, 2020, 81% and 83% respectively, of the total of Available-for-Sale securities with gross unrealized losses were considered investment grade. The following tables present a rollforward of the allowance for credit losses on Available-for-Sale securities:
Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains (losses) were as follows:
There were no credit losses for the three months ended March 31, 2021. Credit losses for the three months ended March 31, 2020 primarily related to recording an allowance for credit losses on certain corporate debt securities, primarily in the oil and gas industry. See Note 14 for a rollforward of net unrealized investment gains (losses) included in AOCI. Available-for-Sale securities by contractual maturity as of March 31, 2021 were as follows:
Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities were not included in the maturities distribution.
|
Financing Receivables |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financing Receivables [Text Block] | Financing receivables are comprised of commercial loans, consumer loans, and the deposit receivable. Allowance for Credit Losses The following tables present a rollforward of the allowance for credit losses for the three months ended March 31:
(1) Prior to January 1, 2020, the allowance for credit losses was based on an incurred loss model that did not require estimating expected credit losses over the expected life of the asset. As of March 31, 2021 and December 31, 2020, accrued interest on commercial loans was $15 million and $14 million, respectively, and is recorded in accrued investment income on the Consolidated Balance Sheets and excluded from the amortized cost basis of commercial loans. Purchases and Sales During the three months ended March 31, 2021 and 2020, the Company purchased $9 million and $41 million, respectively, of syndicated loans, and sold $3 million and $7 million, respectively, of syndicated loans. The Company has not acquired any loans with deteriorated credit quality as of the acquisition date. Credit Quality Information Nonperforming loans were $2 million and $7 million as of March 31, 2021 and December 31, 2020, respectively. All other loans were considered to be performing. Commercial Loans Commercial Mortgage Loans The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on commercial mortgage loans. Loan-to-value ratio is the primary credit quality indicator included in this review. Based on this review, the commercial mortgage loans are assigned an internal risk rating, which management updates when credit risk changes. Commercial mortgage loans which management has assigned its highest risk rating were less than 1% of total commercial mortgage loans as of both March 31, 2021 and December 31, 2020. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. Total commercial mortgage loan modifications through March 31, 2021 due to the COVID-19 pandemic consisted of 88 loans with a total unpaid balance of $360 million. Modifications primarily consisted of short-term forbearance and interest only payments. As of March 31, 2021, there was one loan remaining that was modified due to COVID-19 with interest only payments with an unpaid balance of $10 million. All other loans returned to their normal payment schedules. Total commercial mortgage loans past due were nil as of both March 31, 2021 and December 31, 2020. The tables below present the amortized cost basis of commercial mortgage loans by year of origination and loan-to-value ratio:
Loan-to-value ratio is based on income and expense data provided by borrowers at least annually and long-term capitalization rate assumptions based on property type. In addition, the Company reviews the concentrations of credit risk by region and property type. Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows:
Concentrations of credit risk of commercial mortgage loans by property type were as follows:
Syndicated Loans The recorded investment in syndicated loans as of March 31, 2021 and December 31, 2020 was $420 million and $446 million, respectively. The Company’s syndicated loan portfolio is diversified across industries and issuers. Total syndicated loans past due were nil and $2 million as of March 31, 2021 and December 31, 2020, respectively. The Company assigns an internal risk rating to each syndicated loan in its portfolio ranging from 1 through 5, with 5 reflecting the lowest quality. The tables below present the amortized cost basis of syndicated loans by origination year and internal risk rating:
Policy Loans Policy loans do not exceed the cash surrender value at origination. As there is minimal risk of loss related to policy loans, there is no allowance for credit losses. Deposit Receivable The deposit receivable was $1.4 billion as of both March 31, 2021 and December 31, 2020. The deposit receivable is fully collateralized by the fair value of the assets held in a trust. Based on management’s evaluation of the nature of the underlying assets and the potential for changes in the collateral value, there was no allowance for credit losses for the deposit receivable as of both March 31, 2021 and December 31, 2020. Troubled Debt Restructurings There were no loans accounted for as a troubled debt restructuring by the Company during each of the three months ended March 31, 2021 and 2020. There are no commitments to lend additional funds to borrowers whose loans have been restructured.
|
Deferred Acquisition Costs and Deferred Sales Inducement Costs |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Acquisition Costs and Deferred Sales Inducement Costs | The balances of and changes in DAC were as follows:
The balances of and changes in DSIC, which is included in other assets, were as follows:
|
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | Policyholder account balances, future policy benefits and claims consisted of the following:
(1) Includes fixed deferred annuities, non-life contingent fixed payout annuities and fixed deferred indexed annuity host contracts. (2) Includes the fair value of GMAB embedded derivatives that was a net asset as of March 31, 2021 reported as a contra liability. Separate account liabilities consisted of the following:
|
Variable Annuity and Insurance Guarantees |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Annuity and Insurance Guarantees | The majority of the variable annuity contracts offered by the Company contain guaranteed minimum death benefit (“GMDB”) provisions. The Company also offers variable annuities with death benefit provisions that gross up the amount payable by a certain percentage of contract earnings, which are referred to as gain gross-up (“GGU”) benefits. In addition, the Company offers contracts with GMWB and GMAB provisions. The Company previously offered contracts containing guaranteed minimum income benefit (“GMIB”) provisions. Certain UL policies offered by the Company provide secondary guarantee benefits. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities:
(1) Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. The net amount at risk for GMDB, GGU and GMAB is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB is defined as the greater of the present value of the minimum guaranteed annuity payments less the current contract value or zero. The net amount at risk for GMWB is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero. The following table provides information related to insurance guarantees for which the Company has established additional liabilities:
The net amount at risk for UL secondary guarantees is defined as the current guaranteed death benefit amount in excess of the current policyholder account balance. Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows:
(1) The incurred claims for GMWB and GMAB include the change in the fair value of the liabilities (contra liabilities) less paid claims. The liabilities for guaranteed benefits are supported by general account assets. The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits:
|
Debt |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Debt Disclosure [Abstract] | |
Debt | Long-Term Debt The Company has a $500 million unsecured 3.5% surplus note due December 31, 2050 to Ameriprise Financial. The outstanding balance was $500 million as of both March 31, 2021 and December 31, 2020 and is recorded in Long-term debt on the Consolidated Balance Sheets. Short-term Borrowings RiverSource Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Des Moines which provides access to collateralized borrowings. The Company has pledged Available-for-Sale securities consisting of commercial mortgage backed securities to collateralize its obligation under these borrowings. The fair value of the securities pledged is recorded in investments and was $1.2 billion as of both March 31, 2021 and December 31, 2020. The amount of the Company’s liability including accrued interest was $200 million as of both March 31, 2021 and December 31, 2020. The remaining maturity of outstanding FHLB advances was less than two months as of March 31, 2021 and less than three months as of December 31, 2020. The weighted average annualized interest rate on the FHLB advances held as of March 31, 2021 and December 31, 2020 was 0.3% and 0.4%, respectively.
|
Fair Values of Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Text Block | GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale. Valuation Hierarchy The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows: Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. Level 2 Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. Level 3 Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The following tables present the balances of assets and liabilities measured at fair value on a recurring basis:
(1) Amounts are comprised of certain financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. (2) The fair value of the GMWB and GMAB embedded derivatives included $980 million of individual contracts in a liability position and $265 million of individual contracts in an asset position (recorded as a contra liability) as of March 31, 2021. (3) The Company’s adjustment for nonperformance risk resulted in a $500 million cumulative decrease to the embedded derivatives as of March 31, 2021. (4) The fair value of the GMWB and GMAB embedded derivatives included $2.4 billion of individual contracts in a liability position and $67 million of individual contracts in an asset position (recorded as a contra liability) as of December 31, 2020. (5) The Company’s adjustment for nonperformance risk resulted in a $727 million cumulative decrease to the embedded derivatives as of December 31, 2020. The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis:
(1) Included in interest credited to fixed accounts in the Consolidated Statements of Income. (2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $(167) million and $1.8 billion, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual for the three months ended March 31, 2021 and 2020, respectively. Securities transferred from Level 3 primarily represent securities with fair values that are obtained from a third-party pricing service with observable inputs. The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:
(1) The weighted average for the spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security’s market value as a percentage of the aggregate market value of the securities. (2) The weighted average for the spread to swap rates for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to swap divided by the aggregate balances of the tranches. (3) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. (4) The weighted average surrender rate is weighted based on the benefit base of each contract and represents the average assumption in the current year including the effect of a dynamic surrender formula. (5) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. (6) The weighted average utilization rate represents the average assumption for the current year, weighting each policy evenly. The calculation excludes policies that have already started taking withdrawals. (7) Market volatility is implied volatility of fund of funds and managed volatility funds. (8) The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit. Level 3 measurements not included in the table above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company. Uncertainty of Fair Value Measurements Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in the annual default rate used in the fair value measurement of Level 3 asset backed securities in isolation, generally, would have resulted in a significantly lower (higher) fair value measurement and significant increases (decreases) in loss severity in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in the yield/spread to swap rates in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would have resulted in a significantly lower (higher) fair value measurement. Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurements of the fixed deferred indexed annuity embedded derivatives and structured variable annuity embedded derivatives in isolation would have resulted in a significantly lower (higher) liability value. Significant increases (decreases) in utilization and volatility used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would have resulted in a significantly higher (lower) liability value. Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would have resulted in a significantly lower (higher) liability value. Utilization of guaranteed withdrawals and surrender rates vary with the type of rider, the duration of the policy, the age of the contractholder, the distribution channel and whether the value of the guaranteed benefit exceeds the contract accumulation value. Determination of Fair Value The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy. Assets Cash Equivalents Cash equivalents include time deposits and other highly liquid investments with original or remaining maturities at the time of purchase of 90 days or less. Actively traded money market funds are measured at their NAV and classified as Level 1. U.S. Treasuries are also classified as Level 1. The Company’s remaining cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization. Available-for-Sale Securities When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques. Level 1 securities primarily include U.S. Treasuries. Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. Level 3 securities primarily include certain corporate bonds, non-agency residential mortgage backed securities, commercial mortgage backed securities and asset backed securities. The fair value of corporate bonds, non-agency residential mortgage backed securities, commercial mortgage backed securities and certain asset backed securities classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote. The fair value of affiliated asset backed securities is determined using a discounted cash flow model. Inputs used to determine the expected cash flows include assumptions about discount rates and default, prepayment and recovery rates of the underlying assets. Given the significance of the unobservable inputs to this fair value measurement, the fair value of the investment in the affiliated asset backed securities is classified as Level 3. In consideration of the above, management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise. Separate Account Assets The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy. Other Assets Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial as of both March 31, 2021 and December 31, 2020. See Note 12 and Note 13 for further information on the credit risk of derivative instruments and related collateral. Liabilities Policyholder Account Balances, Future Policy Benefits and Claims There is no active market for the transfer of the Company’s embedded derivatives attributable to the provisions of certain variable annuity riders, fixed deferred indexed annuity, structured variable annuity and IUL products. The Company values the embedded derivatives attributable to the provisions of certain variable annuity riders using internal valuation models. These models calculate fair value as the present value of future expected benefit payments less the present value of future expected rider fees attributable to the embedded derivative feature. The projected cash flows used by these models include observable capital market assumptions and incorporate significant unobservable inputs related to implied volatility as well as contractholder behavior assumptions that include margins for risk, all of which the Company believes a market participant would expect. The fair value also reflects a current estimate of the Company’s nonperformance risk specific to these embedded derivatives. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims. The Company uses a discounted cash flow model to determine the fair value of the embedded derivatives associated with the provisions of its equity index annuity product. The projected cash flows generated by this model are based on significant observable inputs related to interest rates, volatilities and equity index levels and, therefore, are classified as Level 2. The Company uses discounted cash flow models including Black-Scholes calculations to determine the fair value of the embedded derivatives associated with the provisions of its fixed deferred indexed annuity, structured variable annuity and IUL products. The structured variable annuity product is a limited flexible purchase payment annuity that offers 45 different indexed account options providing equity market exposure and a fixed account. Each indexed account includes a protection option (a buffer or a floor). If the index has a negative return, contractholder losses will be reduced by buffer or limited to a floor. The portion allocated to an indexed account is accounted for as an embedded derivative. The fair value of fixed deferred indexed annuity, structured variable annuity and IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company’s nonperformance risk. Given the significance of the nonperformance risk assumption to the fair value, the fixed deferred indexed annuity, structured variable annuity and IUL embedded derivatives are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims. Other Liabilities Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of both March 31, 2021 and December 31, 2020. See Note 12 and Note 13 for further information on the credit risk of derivative instruments and related collateral. Fair Value on a Nonrecurring Basis The Company assesses its investment in affordable housing partnerships for impairment. The investments that are determined to be impaired are written down to their fair value. The Company uses a discounted cash flow model to measure the fair value of these investments. Inputs to the discounted cash flow model are estimates of future net operating losses and tax credits available to the Company and discount rates based on market condition and the financial strength of the syndicator (general partner). The balance of affordable housing partnerships measured at fair value on a nonrecurring basis was $97 million and $101 million as of March 31, 2021 and December 31, 2020, respectively, and is classified as Level 3 in the fair value hierarchy. Asset and Liabilities Not Reported at Fair Value The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:
Other investments include syndicated loans and the Company’s membership in the FHLB. Other receivables include the deposit receivable. See Note 6 for additional information on mortgage loans, policy loans, syndicated loans and the deposit receivable. Policyholder account balances, future policy benefits and claims includes fixed annuities in deferral status, non-life contingent fixed annuities in payout status, indexed and structured variable annuity host contracts, and the fixed portion of a small number of variable annuity contracts classified as investment contracts. See Note 8 for additional information on these liabilities. Short-term borrowings include FHLB borrowings. Long-term debt includes the surplus note with Ameriprise Financial. See Note 10 for further information on short-term borrowings and long-term debt. Other liabilities include future funding commitments to affordable housing partnerships and other real estate partnerships. Separate account liabilities are related to certain annuity products that are classified as investment contracts.
|
Offsetting Assets and Liabilities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting Assets and Liabilities [Text Block] | Certain financial instruments and derivative instruments are eligible for offset in the Consolidated Balance Sheets. The Company’s derivative instruments are subject to master netting and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s assets subject to master netting arrangements:
(1) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements:
(1) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. In the tables above, the amount of assets or liabilities presented are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables. When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral. Freestanding derivative instruments are reflected in other assets and other liabilities. Cash collateral pledged by the Company is reflected in other assets and cash collateral accepted by the Company is reflected in other liabilities. See Note 13 for additional disclosures related to the Company’s derivative instruments.
|
Derivatives and Hedging Activities |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivatives and Hedging Activities [Text Block] | 13. Derivatives and Hedging Activities Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations. Certain of the Company’s freestanding derivative instruments are subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Consolidated Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 12 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral. Generally, the Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives:
N/A Not applicable. (1) The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. (2) The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, fixed deferred indexed annuity and structured variable annuity embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. (3) The fair value of the Company’s derivative liabilities after considering the effects of master netting arrangements, cash collateral held by the same counterparty and the fair value of net embedded derivatives was $2.2 billion and $3.7 billion as of March 31, 2021 and December 31, 2020, respectively. See Note 12 for additional information related to master netting arrangements and cash collateral. (4) The fair value of the GMWB and GMAB embedded derivatives as of March 31, 2021 included $980 million of individual contracts in a liability position and $265 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2020 included $2.4 billion of individual contracts in a liability position and $67 million of individual contracts in an asset position. See Note 11 for additional information regarding the Company’s fair value measurement of derivative instruments. As of March 31, 2021 and December 31, 2020, investment securities with a fair value of $292 million and $325 million, respectively, were received as collateral to meet contractual obligations under derivative contracts, of which $292 million and $325 million, respectively, may be sold, pledged or rehypothecated by the Company. As of both March 31, 2021 and December 31, 2020, the Company had sold, pledged, or rehypothecated none of these securities. In addition, as of both March 31, 2021 and December 31, 2020, non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Consolidated Balance Sheets. The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income:
The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company. Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The indexed portion of structured variable annuities and the GMAB and non-life contingent GMWB provisions are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. The Company economically hedges the aggregate exposure related to the indexed portion of structured variable annuities and the GMAB and non-life contingent GMWB provisions using options, swaptions, swaps and futures. The deferred premium associated with certain of the above options and swaptions is paid or received semi-annually over the life of the contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options and swaptions as of March 31, 2021:
(1) 2021 amounts represent the amounts payable and receivable for the period from April 1, 2021 to December 31, 2021. Actual timing and payment amounts may differ due to future settlements, modifications or exercises of the contracts prior to the full premium being paid or received. The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. As a means of economically hedging these risks, the Company may use a combination of futures, options, swaps and swaptions. Certain of the macro hedge derivatives may contain settlement provisions linked to both equity returns and interest rates. The Company’s macro hedge derivatives that contain settlement provisions linked to both equity returns and interest rates, if any, are shown in other contracts in the tables above. Fixed deferred indexed annuity, structured variable annuity and IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to fixed deferred indexed annuity, structured variable annuity and IUL products will positively or negatively impact earnings over the life of these products. The equity component of fixed deferred indexed annuity, structured variable annuity and IUL product obligations are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts. Cash Flow Hedges During both the three months ended March 31, 2021 and 2020, the Company held no derivatives that were designated as cash flow hedges. During both the three months ended March 31, 2021 and 2020, no hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy. Credit Risk Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting and collateral arrangements whenever practical. See Note 12 for additional information on the Company’s credit exposure related to derivative assets. Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of the Company’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. As of March 31, 2021 and December 31, 2020, the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $261 million and $324 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of March 31, 2021 and December 31, 2020 was $258 million and $324 million, respectively. If the credit contingent provisions of derivative contracts in a net liability position as of March 31, 2021 and December 31, 2020 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been $3 million and nil on March 31, 2021 and December 31, 2020, respectively.
|
Shareholder's Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholder's Equity [Text Block] | The following table provides the amounts related to each component of OCI:
(1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period. (2) Reclassification amounts are recorded in net realized investment gains (losses). Other comprehensive income (loss) related to net unrealized gains (losses) on securities includes three components: (i) unrealized gains (losses) that arose from changes in the fair value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit impairments to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates. The following table presents the changes in the balances of each component of AOCI, net of tax:
|
Income Taxes |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 15. Income Taxes The Company’s effective tax rate was 9.1% and 8.5% for the three months ended March 31, 2021 and 2020, respectively. The effective tax rate for the three months ended March 31, 2021 is lower than the statutory rate as a result of tax preferred items including low income housing tax credits, foreign tax credits and the dividends received deduction. The effective tax rate for the three months ended March 31, 2020 was lower than the statutory rate primarily due to previous tax law changes that resulted in a $160 million tax benefit related to the forecasted utilization of a 2020 net operating loss (“NOL”) that was to be applied to previous tax filings, low income housing tax credits, and other tax preferred items. The Company determined the NOL benefit was attributable to current year losses; accordingly, the benefit was recorded in the annual effective tax rate. Included in the Company’s deferred income tax assets are tax benefits related to state net operating losses of $9 million, net of federal benefit, which will expire beginning December 31, 2021. The Company is required to establish a valuation allowance for any portion of the deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established, and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination, (i) future taxable income exclusive of reversing temporary differences and carryforwards, (ii) future reversals of existing taxable temporary differences, (iii) taxable income in prior carryback years, and (iv) tax planning strategies. Based on analysis of the Company’s tax position, management believes it is more likely than not that the results of future operations and implementation of tax planning strategies will not allow the Company to realize certain state deferred tax assets of $2 million and state net operating losses of $9 million; therefore, a valuation allowance of $11 million has been established as of both March 31, 2021 and December 31, 2020. As of both March 31, 2021 and December 31, 2020, the Company had $38 million of gross unrecognized tax benefits. If recognized, approximately $20 million, net of federal tax benefits, of unrecognized tax benefits as of both March 31, 2021 and December 31, 2020 would affect the effective tax rate. It is reasonably possible that the total amount of unrecognized tax benefits will change in the next 12 months. The Company estimates that the total amount of gross unrecognized tax benefits may decrease by approximately $33 million in the next 12 months primarily due to Internal Revenue Service (“IRS”) settlements. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized nil in interest and penalties for both the three months ended March 31, 2021 and 2020. As of both March 31, 2021 and December 31, 2020, the Company had a payable of $2 million related to accrued interest and penalties. The Company files income tax returns as part of its inclusion in the consolidated federal income tax returns of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. The federal statute of limitations are closed on years through 2015, except for one issue for 2014 and 2015 which was claimed on amended returns. The IRS is currently auditing Ameriprise Financial’s U.S. income tax returns for 2016, 2017 and 2018. Ameriprise Financial’s or the Company’s state income tax returns are currently under examination by various jurisdictions for years ranging from 2010 through 2019.
|
Contingencies |
3 Months Ended |
---|---|
Mar. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | Insurance companies have been the subject of increasing regulatory, legislative and judicial scrutiny. Numerous state and federal regulatory agencies have commenced examinations and other inquiries of insurance companies regarding sales and marketing practices (including sales to older consumers and disclosure practices), claims handling, and unclaimed property and escheatment practices and procedures. The Company has cooperated and will continue to cooperate with the applicable regulators. The Company is involved in the normal course of business in a number of other legal and arbitration proceedings concerning matters arising in connection with the conduct of its business activities. The Company believes that it is not a party to, nor are any of its properties the subject of, any pending legal, arbitration or regulatory investigation, examination or proceeding that is likely to have a material adverse effect on its consolidated financial condition, results of operations or liquidity. Notwithstanding the foregoing, it is possible that the outcome of any current or future legal, arbitration or regulatory proceeding could have a material impact on results of operations in any particular reporting period as the proceedings are resolved. Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally. RiverSource Life Insurance Company and RiverSource Life of NY are required by law to be a member of the guaranty fund association in every state where they are licensed to do business. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund associations. The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations (“NOLHGA”) and the amount of its premiums written relative to the industry-wide premium in each state. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated. The Company has a liability for estimated guaranty fund assessments and a related premium tax asset. As of both March 31, 2021 and December 31, 2020, the estimated liability was $12 million. As of both March 31, 2021 and December 31, 2020, the related premium tax asset was $10 million. The expected period over which guaranty fund assessments will be made and the related tax credits recovered is not known.
|
Revenue from Contracts with Customers (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue [Table Text Block] | The following table presents disaggregated revenue from contracts with customers and a reconciliation to total revenues reported on the Consolidated Statements of Income.
|
Investments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-Sale Securities Disclosure [Table Text Block] | Available-for-Sale securities distributed by type were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fixed Maturity Securities by Rating Disclosure [Table Text Block] | A summary of fixed maturity securities by rating was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-Sale Securities Continuous Unrealized Loss Disclosure [Table Text Block] | The following tables summarize the fair value and gross unrealized losses on Available-for-Sale securities, aggregated by major investment type and the length of time that individual securities have been in a continuous unrealized loss position for which no allowance for credit losses has been recorded:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rollforward of allowance for credit losses on Available-for-Sale Securities [Table Text Block] | The following tables present a rollforward of the allowance for credit losses on Available-for-Sale securities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Realized Gains and Losses on Available-for-Sale Securities Disclosure [Table Text Block] | Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains (losses) were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available-for-Sale Securities Contractual Maturity Disclosure [Table Text Block] |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Investment Income [Table Text Block] |
|
Financing Receivables (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rollforward of the Allowance for Loan Losses [Table Text Block] | The following tables present a rollforward of the allowance for credit losses for the three months ended March 31:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Commercial Mortgage Loans by Year of Origination and Loan-to-Value Ratio [Table Text Block] | The tables below present the amortized cost basis of commercial mortgage loans by year of origination and loan-to-value ratio:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Commercial Mortgage Loans by Geographic Region [Table Text Block] | Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Commercial Mortgage Loans by Property Type [Table Text Block] | Concentrations of credit risk of commercial mortgage loans by property type were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Syndicated Loans by Origination Year and Internal Risk Rating [Table Text Block] | The tables below present the amortized cost basis of syndicated loans by origination year and internal risk rating:
|
Deferred Acquisition Costs and Deferred Sales Inducement Costs (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Charges, Insurers [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of balances of and changes in DAC | The balances of and changes in DAC were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of balances of and changes in DSIC | The balances of and changes in DSIC, which is included in other assets, were as follows:
|
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balances, Future Policy Benefits and Claims Disclosure | Policyholder account balances, future policy benefits and claims consisted of the following:
(1) Includes fixed deferred annuities, non-life contingent fixed payout annuities and fixed deferred indexed annuity host contracts. (2) Includes the fair value of GMAB embedded derivatives that was a net asset as of March 31, 2021 reported as a contra liability.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Separate Account Liabilities by Policy Type | Separate account liabilities consisted of the following:
|
Variable Annuity and Insurance Guarantees (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Variable Annuity Guarantees [Table Text Block] | The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities:
(1) Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of UL Secondary Guarantees [Table Text Block] | The following table provides information related to insurance guarantees for which the Company has established additional liabilities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in Additional Liabilities for Variable Annuity and Insurance Guarantees [Table Text Block] | Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows:
(1) The incurred claims for GMWB and GMAB include the change in the fair value of the liabilities (contra liabilities) less paid claims.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Separate Account Balances By Asset Type [Table Text Block] | The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits:
|
Fair Values of Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of balances of assets and liabilities measured at fair value on a recurring basis [Table Text Block] | The following tables present the balances of assets and liabilities measured at fair value on a recurring basis:
(1) Amounts are comprised of certain financial instruments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. (2) The fair value of the GMWB and GMAB embedded derivatives included $980 million of individual contracts in a liability position and $265 million of individual contracts in an asset position (recorded as a contra liability) as of March 31, 2021. (3) The Company’s adjustment for nonperformance risk resulted in a $500 million cumulative decrease to the embedded derivatives as of March 31, 2021. (4) The fair value of the GMWB and GMAB embedded derivatives included $2.4 billion of individual contracts in a liability position and $67 million of individual contracts in an asset position (recorded as a contra liability) as of December 31, 2020. (5) The Company’s adjustment for nonperformance risk resulted in a $727 million cumulative decrease to the embedded derivatives as of December 31, 2020.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis [Table Text Block] | The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis:
(1) Included in interest credited to fixed accounts in the Consolidated Statements of Income. (2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Significant unobservable inputs used in the fair value measurements [Table Text Block] | The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities:
(1) The weighted average for the spread to U.S. Treasuries for corporate debt securities (private placements) is weighted based on the security’s market value as a percentage of the aggregate market value of the securities. (2) The weighted average for the spread to swap rates for asset backed securities is calculated as the sum of each tranche’s balance multiplied by its spread to swap divided by the aggregate balances of the tranches. (3) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. (4) The weighted average surrender rate is weighted based on the benefit base of each contract and represents the average assumption in the current year including the effect of a dynamic surrender formula. (5) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. (6) The weighted average utilization rate represents the average assumption for the current year, weighting each policy evenly. The calculation excludes policies that have already started taking withdrawals. (7) Market volatility is implied volatility of fund of funds and managed volatility funds. (8) The weighted average market volatility represents the average volatility across all contracts, weighted by the size of the guaranteed benefit.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of carrying value and the estimated fair value of financial instruments that are not reported at fair value [Table Text Block] | The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value:
|
Offsetting Assets and Liabilities (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Offsetting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Gross and Net Information About the Company's Assets Subject to Master Netting Arrangements [Table Text Block] | The following tables present the gross and net information about the Company’s assets subject to master netting arrangements:
(1) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Gross and Net Information About the Company's Liabilities Subject to Master Netting Arrangements [Table Text Block] | The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements:
(1) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets.
|
Derivatives and Hedging Activities (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of notional value and gross fair value of derivative instruments, including embedded derivatives [Table Text Block] | The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives:
N/A Not applicable. (1) The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. (2) The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, fixed deferred indexed annuity and structured variable annuity embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. (3) The fair value of the Company’s derivative liabilities after considering the effects of master netting arrangements, cash collateral held by the same counterparty and the fair value of net embedded derivatives was $2.2 billion and $3.7 billion as of March 31, 2021 and December 31, 2020, respectively. See Note 12 for additional information related to master netting arrangements and cash collateral. (4) The fair value of the GMWB and GMAB embedded derivatives as of March 31, 2021 included $980 million of individual contracts in a liability position and $265 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2020 included $2.4 billion of individual contracts in a liability position and $67 million of individual contracts in an asset position.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of gain (loss) on derivative instruments, including embedded derivatives [Table Text Block] | The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of payments to make and receive for options and swaptions [Table Text Block] | The following is a summary of the payments the Company is scheduled to make and receive for these options and swaptions as of March 31, 2021:
(1) 2021 amounts represent the amounts payable and receivable for the period from April 1, 2021 to December 31, 2021.
|
Shareholder's Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of OCI [Table Text Block] | 14. Shareholder’s Equity The following table provides the amounts related to each component of OCI:
(1) Includes impairments on Available-for-Sale securities related to factors other than credit that were recognized in OCI during the period. (2) Reclassification amounts are recorded in net realized investment gains (losses).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of amounts reclassified from AOCI [Table Text Block] | The following table presents the changes in the balances of each component of AOCI, net of tax:
|
Basis of Presentation (Details) |
Mar. 31, 2021
item
|
---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of wholly owned subsidiaries | 1 |
Variable Interest Entities Variable Interest Entities (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Variable Interest Entity [Line Items] | ||
Assets | $ 133,940 | $ 134,424 |
Liabilities | (131,197) | (131,111) |
Affordable Housing And Other Real Estate Limited Partnership Interests | VIEs, not primary beneficiary [Member] | ||
Variable Interest Entity [Line Items] | ||
Assets | 187 | 200 |
Liabilities | (9) | (9) |
Variable Interest Entity, Primary Beneficiary [Member] | ||
Variable Interest Entity [Line Items] | ||
Unfunded commitments | $ 20 | $ 13 |
Variable Interest Entities - Asset and Liability Balances (Details 2) - Variable Interest Entity, Primary Beneficiary [Member] - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Liabilities | ||
Debt | $ 2,671 | $ 1,913 |
CLO debt valued using DCF model | 2,700 | 2,000 |
Recurring basis [Member] | ||
Assets | ||
Investments | 2,642 | 1,918 |
Receivables, Fair Value Disclosure | 17 | 16 |
Other assets | 2 | 2 |
Total assets at fair value | 2,661 | 1,936 |
Liabilities | ||
Debt | 2,671 | 1,913 |
Other liabilities | 256 | 69 |
Total liabilities at fair value | 2,927 | 1,982 |
Recurring basis [Member] | Corporate debt securities [Member] | ||
Assets | ||
Investments | 8 | |
Recurring basis [Member] | Equity Securities | ||
Assets | ||
Investments | 2 | 1 |
Recurring basis [Member] | Syndicated loans [Member] | ||
Assets | ||
Investments | 2,640 | 1,909 |
Recurring basis [Member] | Level 2 [Member] | ||
Assets | ||
Investments | 2,487 | 1,826 |
Receivables, Fair Value Disclosure | 17 | 16 |
Other assets | 2 | |
Total assets at fair value | 2,506 | 1,842 |
Liabilities | ||
Debt | 2,671 | 1,913 |
Other liabilities | 256 | 69 |
Total liabilities at fair value | 2,927 | 1,982 |
Recurring basis [Member] | Level 2 [Member] | Corporate debt securities [Member] | ||
Assets | ||
Investments | 8 | |
Recurring basis [Member] | Level 2 [Member] | Equity Securities | ||
Assets | ||
Investments | 2 | 1 |
Recurring basis [Member] | Level 2 [Member] | Syndicated loans [Member] | ||
Assets | ||
Investments | 2,485 | 1,817 |
Recurring basis [Member] | Level 3 [Member] | ||
Assets | ||
Investments | 155 | 92 |
Other assets | 2 | |
Total assets at fair value | 155 | 94 |
Recurring basis [Member] | Level 3 [Member] | Syndicated loans [Member] | ||
Assets | ||
Investments | $ 155 | $ 92 |
Variable Interest Entities - Changes in Level 3 Assets and Liabilities (Details 3) - Variable Interest Entity, Primary Beneficiary [Member] $ in Millions |
3 Months Ended |
---|---|
Mar. 31, 2021
USD ($)
| |
Syndicated loans [Member] | |
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | |
Balance, at the beginning of the period | $ 92 |
Total Gains (Losses) Included in Net Income | (2) |
Purchases | (59) |
Sales | (10) |
Settlements | (20) |
Transfers into level 3 | 57 |
Transfers out of Level 3 | (25) |
Balance, at the end of the period | 155 |
Changes in unrealized gains (losses) in net income relating to assets held at the end of the period | (1) |
Other assets | |
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | |
Balance, at the beginning of the period | 2 |
Transfers out of Level 3 | (2) |
Balance, at the end of the period | $ 0 |
Variable Interest Entities - FV Options for consolidated CLOs (Details 4) - Variable Interest Entity, Primary Beneficiary [Member] - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Syndicated Loans [Abstract] | ||
Unpaid principal balance | $ 2,690 | $ 1,990 |
Fair Value, Option, Aggregate Differences, Loans and Long-term Receivables | (50) | (81) |
Fair value | 2,640 | 1,909 |
Fair value of loans more than 90 days past due | 1 | 5 |
Fair value of loans in nonaccrual status | 15 | 19 |
Difference between fair value and unpaid principal of loans more than 90 days past due, loans in nonaccrual status or both | 20 | 24 |
Debt | ||
Debt Instrument Unpaid Principal Amount | 2,808 | 2,069 |
Excess unpaid principal over fair value | (137) | (156) |
Carrying value | 2,671 | 1,913 |
CLO debt valued using DCF model | 2,700 | $ 2,000 |
Debt issued | $ 817 |
Variable Interest Entities - CLO Debt - (Details 5) - Variable Interest Entity, Primary Beneficiary [Member] - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt | ||
Carrying value | $ 2,671 | $ 1,913 |
Weighted average interest rate | 2.00% | 2.10% |
Minimum [Member] | ||
Debt | ||
Interest rates | 0.00% | |
Maximum [Member] | ||
Debt | ||
Interest rates | 8.90% |
Investments (AFS by type) (Details) - RiverSource Life - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2020 |
Mar. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Investments | ||||
Amortized cost | $ 20,153 | $ 20,260 | ||
Gross unrealized gains | 2,615 | |||
Gross unrealized losses | (10) | |||
Allowance for credit losses | $ (13) | 0 | (10) | $ 0 |
Fair value | 22,031 | 22,855 | ||
Investments purchased from affiliate | $ 368 | |||
Accrued interest excluded from amortized cost basis on Available-for-Sale securities | 135 | 158 | ||
Fair value of securities owned and pledged as collateral | 2,700 | 2,900 | ||
Fair value of securities owned and pledged as collateral which are eligible for rehypothecation | $ 417 | $ 454 | ||
Fixed maturity securities as percentage of total investments | 85.00% | 85.00% | ||
Corporate debt securities [Member] | ||||
Investments | ||||
Amortized cost | $ 11,289 | $ 10,982 | ||
Gross unrealized gains | 1,426 | 1,903 | ||
Gross unrealized losses | (87) | (2) | ||
Allowance for credit losses | (10) | |||
Fair value | 12,628 | 12,873 | ||
Residential mortgage backed securities [Member] | ||||
Investments | ||||
Amortized cost | 2,650 | 2,888 | ||
Gross unrealized gains | 96 | 115 | ||
Gross unrealized losses | (7) | (1) | ||
Fair value | 2,739 | 3,002 | ||
Commercial mortgage backed securities [Member] | ||||
Investments | ||||
Amortized cost | 3,896 | 3,935 | ||
Gross unrealized gains | 167 | 235 | ||
Gross unrealized losses | (11) | (4) | ||
Fair value | 4,052 | 4,166 | ||
State and municipal obligations [Member] | ||||
Investments | ||||
Amortized cost | 1,025 | 1,050 | ||
Gross unrealized gains | 242 | 295 | ||
Gross unrealized losses | (3) | (1) | ||
Fair value | 1,264 | 1,344 | ||
Asset backed securities [Member] | ||||
Investments | ||||
Amortized cost | 1,064 | 1,168 | ||
Gross unrealized gains | 39 | 45 | ||
Gross unrealized losses | (1) | |||
Fair value | 1,103 | 1,212 | ||
Foreign government bonds and obligations [Member] | ||||
Investments | ||||
Amortized cost | 229 | 236 | ||
Gross unrealized gains | 17 | 22 | ||
Gross unrealized losses | (1) | (1) | ||
Fair value | 245 | 257 | ||
U.S. government and agencies obligations [Member] | ||||
Investments | ||||
Amortized cost | 1 | |||
Fair value | 1 | |||
Total fixed maturities [Member] | ||||
Investments | ||||
Amortized cost | 20,153 | |||
Gross unrealized gains | 1,987 | |||
Gross unrealized losses | (109) | |||
Fair value | 22,031 | |||
Fixed maturity securities rated internally | $ 516 | $ 553 |
Investments (Rating info) (Details) - RiverSource Life - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Investments | ||
Fixed maturities, amortized cost | $ 20,153 | $ 20,260 |
Fixed maturities, fair value | $ 22,031 | $ 22,855 |
Percent of total fair value | 100.00% | 100.00% |
Percentage of securities rated AAA that were GNMA, FNMA and FHLMC | 36.00% | 37.00% |
Investment holdings of single issuer other than GNMA, FNMA and FHLMC greater than 10% of shareholders equity | $ 0 | $ 0 |
Ameriprise Advisor Financing, LLC [Member] | ||
Investments | ||
Investment holdings of single issuer other than GNMA, FNMA and FHLMC greater than 10% of shareholders equity | 356 | 372 |
AAA [Member] | ||
Investments | ||
Fixed maturities, amortized cost | 6,984 | 7,323 |
Fixed maturities, fair value | $ 7,252 | $ 7,698 |
Percent of total fair value | 33.00% | 34.00% |
AA [Member] | ||
Investments | ||
Fixed maturities, amortized cost | $ 1,026 | $ 1,036 |
Fixed maturities, fair value | $ 1,212 | $ 1,266 |
Percent of total fair value | 6.00% | 6.00% |
A [Member] | ||
Investments | ||
Fixed maturities, amortized cost | $ 2,481 | $ 2,663 |
Fixed maturities, fair value | $ 2,900 | $ 3,235 |
Percent of total fair value | 13.00% | 14.00% |
BBB [Member] | ||
Investments | ||
Fixed maturities, amortized cost | $ 8,359 | $ 7,770 |
Fixed maturities, fair value | $ 9,238 | $ 9,026 |
Percent of total fair value | 42.00% | 39.00% |
Below investment grade [Member] | ||
Investments | ||
Fixed maturities, amortized cost | $ 1,303 | $ 1,468 |
Fixed maturities, fair value | $ 1,429 | $ 1,630 |
Percent of total fair value | 6.00% | 7.00% |
Investments (EITF info-Number of securities and unrealized losses) (Details) - RiverSource Life $ in Millions |
Mar. 31, 2021
USD ($)
item
|
Dec. 31, 2020
USD ($)
item
|
---|---|---|
Number of Securities | ||
Less than 12 months | item | 164 | 56 |
12 months or more | item | 32 | 25 |
Total | item | 196 | 81 |
Fair Value | ||
Less than 12 months | $ 2,875 | $ 526 |
12 months or more | 152 | 134 |
Total | 3,027 | 660 |
Unrealized Losses | ||
Less than 12 months | (106) | (5) |
12 months or more | (3) | (5) |
Total | $ (109) | $ (10) |
investment grade AFS securities with gross unrealized losses | 81.00% | 83.00% |
Corporate debt securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 84 | 26 |
12 months or more | item | 2 | 1 |
Total | item | 86 | 27 |
Fair Value | ||
Less than 12 months | $ 1,948 | $ 228 |
12 months or more | 16 | 12 |
Total | 1,964 | 240 |
Unrealized Losses | ||
Less than 12 months | (87) | (1) |
12 months or more | (1) | |
Total | $ (87) | $ (2) |
Residential mortgage backed securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 16 | 11 |
12 months or more | item | 13 | 7 |
Total | item | 29 | 18 |
Fair Value | ||
Less than 12 months | $ 329 | $ 47 |
12 months or more | 22 | 14 |
Total | 351 | 61 |
Unrealized Losses | ||
Less than 12 months | (7) | (1) |
Total | $ (7) | $ (1) |
Commercial mortgage backed securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 32 | 12 |
12 months or more | item | 8 | 7 |
Total | item | 40 | 19 |
Fair Value | ||
Less than 12 months | $ 518 | $ 179 |
12 months or more | 100 | 60 |
Total | 618 | 239 |
Unrealized Losses | ||
Less than 12 months | (10) | (3) |
12 months or more | (1) | (1) |
Total | $ (11) | $ (4) |
State and municipal obligations [Member] | ||
Number of Securities | ||
Less than 12 months | item | 28 | 2 |
12 months or more | item | 2 | 1 |
Total | item | 30 | 3 |
Fair Value | ||
Less than 12 months | $ 75 | $ 4 |
12 months or more | 7 | 4 |
Total | 82 | 8 |
Unrealized Losses | ||
Less than 12 months | (2) | |
12 months or more | (1) | (1) |
Total | $ (3) | $ (1) |
Asset backed securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 4 | |
12 months or more | item | 2 | |
Total | item | 6 | |
Fair Value | ||
Less than 12 months | $ 65 | |
12 months or more | 36 | |
Total | 101 | |
Unrealized Losses | ||
12 months or more | (1) | |
Total | $ (1) | |
Foreign government bonds and obligations [Member] | ||
Number of Securities | ||
Less than 12 months | item | 4 | 1 |
12 months or more | item | 7 | 7 |
Total | item | 11 | 8 |
Fair Value | ||
Less than 12 months | $ 5 | $ 3 |
12 months or more | 7 | 8 |
Total | 12 | 11 |
Unrealized Losses | ||
12 months or more | (1) | (1) |
Total | $ (1) | $ (1) |
Investments Investments (Allowance for credit losses rollforward) (Details) - RiverSource Life - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Rollforward of available-for-Sale securities allowance for credit losses | ||
Beginning balance | $ 10 | $ 0 |
Charge-offs | (10) | |
Additions for which credit losses were not previously recognized | 13 | |
Ending balance | $ 0 | $ 13 |
Investments Investments (Realized GL info) (Details) - RiverSource Life - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Investments | ||
Gross realized investment gains | $ 49 | $ 6 |
Gross realized investment losses | (1) | |
Credit Losses | (13) | |
Total | $ 49 | $ (8) |
Investments (AFS contractual maturity) (Details) - RiverSource Life - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Amortized Cost | ||
Due within one year | $ 453 | |
Due after one year through five years | 4,445 | |
Due after five years through 10 years | 3,417 | |
Due after 10 years | 4,228 | |
Total having single maturity dates | 12,543 | |
Amortized cost | 20,153 | $ 20,260 |
Fair Value | ||
Due within one year | 460 | |
Due after one year through five years | 4,734 | |
Due after five years through 10 years | 3,558 | |
Due after 10 years | 5,385 | |
Total having single maturity dates | 14,137 | |
Total fair value | 22,031 | 22,855 |
Residential mortgage backed securities [Member] | ||
Amortized Cost | ||
Without single maturity dates | 2,650 | |
Amortized cost | 2,650 | 2,888 |
Fair Value | ||
Without single maturity dates | 2,739 | |
Total fair value | 2,739 | 3,002 |
Commercial mortgage backed securities [Member] | ||
Amortized Cost | ||
Without single maturity dates | 3,896 | |
Amortized cost | 3,896 | 3,935 |
Fair Value | ||
Without single maturity dates | 4,052 | |
Total fair value | 4,052 | 4,166 |
Asset backed securities [Member] | ||
Amortized Cost | ||
Without single maturity dates | 1,064 | |
Amortized cost | 1,064 | 1,168 |
Fair Value | ||
Without single maturity dates | 1,103 | |
Total fair value | $ 1,103 | $ 1,212 |
Investments (Net Inv Inc summary) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Net Investment Income [Line Items] | ||
Gross investment income | $ 252 | $ 229 |
Less: investment expenses | 5 | 6 |
Total | 247 | 223 |
Fixed maturities [Member] | ||
Net Investment Income [Line Items] | ||
Gross investment income | 189 | 201 |
Mortgage loans [Member] | ||
Net Investment Income [Line Items] | ||
Gross investment income | 28 | 29 |
Other investments [Member] | ||
Net Investment Income [Line Items] | ||
Gross investment income | $ 35 | $ (1) |
Financing Receivables (Allowance for Credit Losses) (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Nonperforming | |||
Rollforward of the allowance for loan losses | |||
Nonperforming loans | $ 2 | $ 7 | |
Commercial loans [Member] | |||
Rollforward of the allowance for loan losses | |||
Beginning balance | $ 20 | ||
Provisions | (2) | 9 | |
Ending balance | 33 | 32 | |
Accrued interest on commercial loans | 15 | 14 | |
Commercial loans [Member] | Cumulative Effect, Period of Adoption, Adjustment [Member] | |||
Rollforward of the allowance for loan losses | |||
Beginning balance | 3 | ||
Commercial loans [Member] | Cumulative Effect, Period of Adoption, Adjusted Balance [Member] | |||
Rollforward of the allowance for loan losses | |||
Beginning balance | 35 | 23 | |
Syndicated loans [Member] | |||
Rollforward of the allowance for loan losses | |||
Loans purchased | 9 | 41 | |
Loans sold | 3 | $ 7 | |
Nonperforming loans | $ 0 | $ 2 |
Financing Receivables (Credit Quality Information Text) (Details) |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2021
USD ($)
loan
|
Mar. 31, 2020
USD ($)
|
Dec. 31, 2020
USD ($)
loan
|
|
Nonperforming | |||
Credit quality information [Line Items] | |||
Past due | $ 2,000,000 | $ 7,000,000 | |
Syndicated loans [Member] | |||
Credit quality information [Line Items] | |||
Past due | 0 | 2,000,000 | |
Total loans, net | 420,000,000 | 446,000,000 | |
Loans purchased | 9,000,000 | $ 41,000,000 | |
Loans sold | 3,000,000 | $ 7,000,000 | |
Commercial mortgage loans [Member] | |||
Credit quality information [Line Items] | |||
Past due | $ 0 | $ 0 | |
Percent of commercial mortgage loans with highest risk rating | 1.00% | 1.00% | |
Total loans, net | $ 2,569,000,000 | $ 2,602,000,000 | |
Financing Receivable, Modifications, Number of Contracts | loan | 1 | 88 | |
Impaired Financing Receivable, Unpaid Principal Balance | $ 10,000,000 | $ 360 | |
Commercial loans [Member] | |||
Credit quality information [Line Items] | |||
Accrued interest on commercial loans | $ 15,000,000 | $ 14,000,000 |
Financing Receivables (Credit Quality Information Tables) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Syndicated loans [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | $ 7 | $ 37 |
Originated in 2019 | 37 | 74 |
Originated in 2018 | 66 | 89 |
Originated in 2017 | 87 | 120 |
Originated in 2016 | 110 | 37 |
Originated prior to 2016 | 113 | 89 |
Total loans, gross | 420 | 446 |
Syndicated loans [Member] | Internal Risk Rating 5 [Member] | ||
Commercial loans [Line Items] | ||
Originated prior to 2016 | 2 | 2 |
Total loans, gross | 2 | 2 |
Syndicated loans [Member] | Internal Risk Rating 4 [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2018 | 3 | |
Originated in 2017 | 1 | 7 |
Originated in 2016 | 5 | |
Originated prior to 2016 | 5 | 7 |
Total loans, gross | 11 | 17 |
Syndicated loans [Member] | Internal Risk Rating 3 [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2019 | 2 | 7 |
Originated in 2018 | 6 | 6 |
Originated in 2017 | 10 | 19 |
Originated in 2016 | 13 | 10 |
Originated prior to 2016 | 27 | 18 |
Total loans, gross | 58 | 60 |
Syndicated loans [Member] | Internal Risk Rating 2 [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 4 | 23 |
Originated in 2019 | 21 | 42 |
Originated in 2018 | 38 | 45 |
Originated in 2017 | 41 | 51 |
Originated in 2016 | 51 | 10 |
Originated prior to 2016 | 34 | 32 |
Total loans, gross | 189 | 203 |
Syndicated loans [Member] | Internal Risk Rating 1 [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 3 | 14 |
Originated in 2019 | 14 | 25 |
Originated in 2018 | 22 | 35 |
Originated in 2017 | 35 | 43 |
Originated in 2016 | 41 | 17 |
Originated prior to 2016 | 45 | 30 |
Total loans, gross | 160 | 164 |
Syndicated loans [Member] | Assets, Total | ||
Commercial loans [Line Items] | ||
Total loans, gross | 420 | 446 |
Commercial mortgage loans [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 20 | 127 |
Originated in 2019 | 126 | 240 |
Originated in 2018 | 239 | 181 |
Originated in 2017 | 178 | 267 |
Originated in 2016 | 263 | 222 |
Originated prior to 2016 | 1,743 | 1,565 |
Total loans, gross | 2,569 | 2,602 |
Less: allowance for loan losses | 28 | 28 |
Total loans, net | $ 2,541 | $ 2,574 |
Percentage of commercial mortgage loans | 100.00% | 100.00% |
Commercial mortgage loans [Member] | Retail [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 834 | $ 843 |
Percentage of commercial mortgage loans | 33.00% | 32.00% |
Commercial mortgage loans [Member] | Office [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 346 | $ 358 |
Percentage of commercial mortgage loans | 13.00% | 14.00% |
Commercial mortgage loans [Member] | Apartments [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 678 | $ 680 |
Percentage of commercial mortgage loans | 26.00% | 26.00% |
Commercial mortgage loans [Member] | Industrial [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 395 | $ 401 |
Percentage of commercial mortgage loans | 15.00% | 16.00% |
Commercial mortgage loans [Member] | Mixed use [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 75 | $ 76 |
Percentage of commercial mortgage loans | 3.00% | 3.00% |
Commercial mortgage loans [Member] | Hotel [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 49 | $ 49 |
Percentage of commercial mortgage loans | 2.00% | 2.00% |
Commercial mortgage loans [Member] | Other [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 192 | $ 195 |
Percentage of commercial mortgage loans | 8.00% | 7.00% |
Commercial mortgage loans [Member] | South Atlantic [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 658 | $ 663 |
Percentage of commercial mortgage loans | 26.00% | 25.00% |
Commercial mortgage loans [Member] | Pacific [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 774 | $ 784 |
Percentage of commercial mortgage loans | 30.00% | 30.00% |
Commercial mortgage loans [Member] | Mountain [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 228 | $ 250 |
Percentage of commercial mortgage loans | 9.00% | 10.00% |
Commercial mortgage loans [Member] | West North Central [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 189 | $ 234 |
Percentage of commercial mortgage loans | 7.00% | 10.00% |
Commercial mortgage loans [Member] | East North Central [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 247 | $ 192 |
Percentage of commercial mortgage loans | 10.00% | 7.00% |
Commercial mortgage loans [Member] | Middle Atlantic [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 163 | $ 165 |
Percentage of commercial mortgage loans | 6.00% | 6.00% |
Commercial mortgage loans [Member] | West South Central [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 154 | $ 156 |
Percentage of commercial mortgage loans | 6.00% | 6.00% |
Commercial mortgage loans [Member] | New England [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 46 | $ 47 |
Percentage of commercial mortgage loans | 2.00% | 2.00% |
Commercial mortgage loans [Member] | East South Central [Member] | ||
Commercial loans [Line Items] | ||
Total loans, gross | $ 110 | $ 111 |
Percentage of commercial mortgage loans | 4.00% | 4.00% |
Commercial mortgage loans [Member] | Greater than 100 Percent [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | $ 0 | |
Originated in 2019 | 0 | |
Originated in 2018 | 0 | $ 2 |
Originated in 2017 | 2 | |
Originated in 2016 | 0 | |
Originated prior to 2016 | 15 | 10 |
Total loans, gross | 17 | 12 |
Commercial mortgage loans [Member] | 80 to 100 Percent [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 0 | 15 |
Originated in 2019 | 15 | 16 |
Originated in 2018 | 19 | 9 |
Originated in 2017 | 8 | 3 |
Originated in 2016 | 3 | 7 |
Originated prior to 2016 | 22 | 15 |
Total loans, gross | 67 | 65 |
Commercial mortgage loans [Member] | 60 to 80 Percent [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 13 | 85 |
Originated in 2019 | 77 | 152 |
Originated in 2018 | 148 | 27 |
Originated in 2017 | 27 | 29 |
Originated in 2016 | 33 | 46 |
Originated prior to 2016 | 174 | 141 |
Total loans, gross | 472 | 480 |
Commercial mortgage loans [Member] | 40 to 60 Percent [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 7 | 20 |
Originated in 2019 | 27 | 50 |
Originated in 2018 | 44 | 74 |
Originated in 2017 | 83 | 147 |
Originated in 2016 | 132 | 111 |
Originated prior to 2016 | 661 | 543 |
Total loans, gross | 954 | 945 |
Commercial mortgage loans [Member] | Less than 40 Percent [Member] | ||
Commercial loans [Line Items] | ||
Originated in 2020 | 0 | 7 |
Originated in 2019 | 7 | 22 |
Originated in 2018 | 28 | 69 |
Originated in 2017 | 58 | 88 |
Originated in 2016 | 95 | 58 |
Originated prior to 2016 | 871 | 856 |
Total loans, gross | $ 1,059 | $ 1,100 |
Financing Receivables - Additional Information (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Allowance for credit losses | ||
Reinsurance deposit receivable | $ 1,400 | |
Consumer Portfolio Segment [Member] | Policy Loan [Member] | ||
Allowance for credit losses | ||
Allowance for credit Loss | 0 | $ 0 |
Unallocated Financing Receivables [Member] | Deposit Receivable [Member] | ||
Allowance for credit losses | ||
Allowance for credit Loss | $ 0 | $ 0 |
Financing Receivables (Troubled Debt Restructurings) (Details) - USD ($) |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Receivables [Abstract] | ||
Loans restructured | $ 0 | $ 0 |
Commitments to lend additional funds to borrowers for restructured loans | $ 0 |
Deferred Acquisition Costs and Deferred Sales Inducement Costs (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Balances of and changes in DAC | ||
Balance at the beginning of the period | $ 2,508 | $ 2,673 |
Capitalization of acquisition costs | 62 | 57 |
Amortization | (2) | (503) |
Impact of change in net unrealized (gains) losses on securities | 93 | 118 |
Balance at the end of the period | 2,661 | 2,345 |
Balances of and changes in DSIC | ||
Balance at the beginning of the period | 187 | 216 |
Amortization | (3) | (36) |
Impact of change in net unrealized (gains) losses on securities | 4 | 15 |
Balance at the end of the period | $ 188 | $ 195 |
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Balances by product) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
|||||
---|---|---|---|---|---|---|---|
Policyholder account balances | $ 21,546 | $ 21,002 | |||||
Future policy benefits | 10,957 | 12,799 | |||||
Policy claims and other policyholders’ funds | 193 | 185 | |||||
Policyholder account balances, future policy benefits and claims | 32,696 | 33,986 | |||||
Fixed annuities [Member] | |||||||
Policyholder account balances | 8,401 | [1] | 8,531 | ||||
Variable annuity fixed sub-accounts [Member] | |||||||
Policyholder account balances | 5,075 | 5,104 | |||||
UL/VUL insurance [Member] | |||||||
Policyholder account balances | 3,110 | 3,122 | |||||
IUL [Member] | |||||||
Policyholder account balances | 2,336 | 2,269 | |||||
Structured Variable Annuities [Member] | |||||||
Policyholder account balances | 2,027 | 1,371 | |||||
Other life Insurance [Member] | |||||||
Policyholder account balances | 597 | 605 | |||||
Variable annuity GMWB [Member] | |||||||
Future policy benefits | 1,479 | 3,049 | |||||
Variable annuity GMAB [Member] | |||||||
Future policy benefits | (22) | [2] | 1 | ||||
Other annuity liabilities [Member] | |||||||
Future policy benefits | 173 | 211 | |||||
Fixed annuity life contingent liabilities [Member] | |||||||
Future policy benefits | 1,346 | 1,370 | |||||
Life and disability income insurance [Member] | |||||||
Future policy benefits | 1,179 | 1,187 | |||||
Long term care insurance [Member] | |||||||
Future policy benefits | 5,558 | 5,722 | |||||
UL/VUL and other life insurance additional liabilities [Member] | |||||||
Future policy benefits | $ 1,244 | $ 1,259 | |||||
|
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Separate Account Liabilities) (Details 2) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Separate Accounts Disclosure [Abstract] | ||
Variable annuity | $ 79,862 | $ 79,299 |
VUL insurance | 8,539 | 8,226 |
Other insurance | 32 | 31 |
Total | $ 88,433 | $ 87,556 |
Variable Annuity and Insurance Guarantees (VA Guarantees Details) (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
||||
GMDB [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | [1] | $ 84,325 | $ 83,781 | ||
Contract value in separate accounts | [1] | 79,279 | 78,705 | ||
Net amount at risk | [1] | $ 73 | $ 64 | ||
Weighted average attained age | 68 years | [1] | 68 years | ||
GMDB [Member] | Return of premium [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 67,317 | [1] | $ 66,874 | ||
Contract value in separate accounts | 65,396 | [1] | 64,932 | ||
Net amount at risk | $ 7 | [1] | $ 5 | ||
Weighted average attained age | 68 years | [1] | 68 years | ||
GMDB [Member] | Five/six-year reset [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 8,211 | [1] | $ 8,116 | ||
Contract value in separate accounts | 5,486 | [1] | 5,386 | ||
Net amount at risk | $ 7 | [1] | $ 6 | ||
Weighted average attained age | 68 years | [1] | 68 years | ||
GMDB [Member] | One-year ratchet [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 6,093 | [1] | $ 6,094 | ||
Contract value in separate accounts | 5,765 | [1] | 5,763 | ||
Net amount at risk | $ 13 | [1] | $ 8 | ||
Weighted average attained age | 71 years | [1] | 71 years | ||
GMDB [Member] | Five-year ratchet [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 1,437 | [1] | $ 1,436 | ||
Contract value in separate accounts | 1,383 | [1] | 1,381 | ||
Net amount at risk | $ 1 | [1] | $ 0 | ||
Weighted average attained age | 67 years | [1] | 67 years | ||
GMDB [Member] | Other [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 1,267 | [1] | $ 1,261 | ||
Contract value in separate accounts | 1,249 | [1] | 1,243 | ||
Net amount at risk | $ 45 | [1] | $ 45 | ||
Weighted average attained age | 74 years | [1] | 73 years | ||
GGU death benefit [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 1,196 | [1] | $ 1,183 | ||
Contract value in separate accounts | 1,139 | [1] | 1,126 | ||
Net amount at risk | $ 168 | [1] | $ 162 | ||
Weighted average attained age | 72 years | [1] | 71 years | ||
GMIB [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 187 | [1] | $ 187 | ||
Contract value in separate accounts | 174 | [1] | 173 | ||
Net amount at risk | $ 5 | [1] | $ 6 | ||
Weighted average attained age | 71 years | [1] | 71 years | ||
GMWB [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | [1] | $ 52,338 | $ 52,114 | ||
Contract value in separate accounts | [1] | 52,260 | 52,024 | ||
Net amount at risk | [1] | $ 210 | $ 186 | ||
Weighted average attained age | 69 years | [1] | 69 years | ||
GMWB [Member] | GMWB standard benefit [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 1,949 | [1] | $ 1,972 | ||
Contract value in separate accounts | 1,944 | [1] | 1,967 | ||
Net amount at risk | $ 1 | [1] | $ 1 | ||
Weighted average attained age | 74 years | [1] | 74 years | ||
GMWB [Member] | GMWB for life [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 50,389 | [1] | $ 50,142 | ||
Contract value in separate accounts | 50,316 | [1] | 50,057 | ||
Net amount at risk | $ 209 | [1] | $ 185 | ||
Weighted average attained age | 69 years | [1] | 69 years | ||
GMAB [Member] | |||||
Variable Annuity Guarantees by Benefit Type | |||||
Total contract value | $ 2,187 | [1] | $ 2,291 | ||
Contract value in separate accounts | 2,186 | [1] | 2,291 | ||
Net amount at risk | $ 0 | [1] | $ 0 | ||
Weighted average attained age | 61 years | [1] | 61 years | ||
|
Variable Annuity and Insurance Guarantees Variable Annuity and Insurance Guarantees (UL Secondary Guarantees) (Details) - UL secondary guarantees [Member] - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Insurance Guarantees by Benefit Type | ||
Net amount at risk | $ 6,573 | $ 6,587 |
Weighted average attained age | 67 years | 67 years |
Variable Annuity and Insurance Guarantees (Liability Rollforward) (Details) - USD ($) $ in Millions |
3 Months Ended | ||||
---|---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
||||
GMDB & GGU [Member] | |||||
Changes in additional liabilities for variable annuity and insurance guarantees | |||||
Beginning Balance | $ 24 | $ 16 | |||
Incurred claims | 3 | 5 | |||
Paid claims | (1) | (2) | |||
Ending Balance | 26 | 19 | |||
GMIB [Member] | |||||
Changes in additional liabilities for variable annuity and insurance guarantees | |||||
Beginning Balance | 6 | 7 | |||
Incurred claims | 0 | 2 | |||
Ending Balance | 6 | 9 | |||
GMWB [Member] | |||||
Changes in additional liabilities for variable annuity and insurance guarantees | |||||
Beginning Balance | 3,049 | 1,462 | |||
Incurred claims | (1,570) | [1] | 2,437 | ||
Ending Balance | 1,479 | 3,899 | |||
GMAB [Member] | |||||
Changes in additional liabilities for variable annuity and insurance guarantees | |||||
Beginning Balance | 1 | (39) | |||
Incurred claims | (23) | [1] | 127 | ||
Ending Balance | (22) | 88 | |||
UL [Member] | |||||
Changes in additional liabilities for variable annuity and insurance guarantees | |||||
Beginning Balance | 916 | 758 | |||
Incurred claims | 32 | 32 | |||
Paid claims | (8) | (12) | |||
Ending Balance | $ 940 | $ 778 | |||
|
Variable Annuity and Insurance Guarantees (Separate Account Balances by Type) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Mutual funds | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | $ 79,497 | $ 78,931 |
Equity [Member] | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | 46,823 | 45,947 |
Bond [Member] | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | 25,614 | 26,073 |
Other [Member] | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | $ 7,060 | $ 6,911 |
Debt - Long-Term Debt (Details) - RiverSource Life - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Debt | ||
Long-term debt | $ 500 | $ 500 |
Unsecured Debt [Member] | ||
Debt | ||
Debt Instrument, Face Amount | $ 500 | |
Interest rate (as a percent) | 3.50% | |
Long-term debt | $ 500 | $ 500 |
Debt - Short-term Borrowings (Details) - RiverSource Life - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Debt | ||
Amount of the liability including accrued interest | $ 200 | $ 200 |
Federal Home Loan Bank borrowings | ||
Debt | ||
Amount of the liability including accrued interest | $ 200 | $ 200 |
Remaining maturity of outstanding amount of short term borrowings | 2 months | 3 months |
Weighted average annualized interest rate | 0.30% | 0.40% |
Commercial mortgage backed securities [Member] | Federal Home Loan Bank borrowings | ||
Debt | ||
Securities pledged as collateral | $ 1,200 | $ 1,200 |
Fair Values of Assets and Liabilities (Recurring) (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
|||||||||||||||
Liabilities | ||||||||||||||||
Individual contracts in an asset position | $ 4,923 | [1] | $ 5,758 | |||||||||||||
GMWB and GMAB embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Individual contracts in a liability position | 980 | 2,400 | ||||||||||||||
Individual contracts in an asset position | 265 | 67 | ||||||||||||||
RiverSource Life | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 22,031 | 22,855 | ||||||||||||||
Separate account assets at NAV | 88,433 | 87,556 | ||||||||||||||
Liabilities | ||||||||||||||||
Cumulative increase (decrease) in embedded derivatives of adjustment for nonperformance risk | (500) | (727) | ||||||||||||||
RiverSource Life | Recurring basis [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 22,031 | 22,855 | ||||||||||||||
Cash equivalents | 2,196 | 3,132 | ||||||||||||||
Other assets: derivative contracts | 4,923 | 5,758 | ||||||||||||||
Separate account assets at NAV | [2] | 88,433 | 87,556 | |||||||||||||
Total assets at fair value | 117,583 | 119,301 | ||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 1,844 | [3] | 3,373 | [4] | ||||||||||||
Other liabilities: derivative contracts | 3,768 | 4,248 | ||||||||||||||
Total liabilities at fair value | 5,612 | 7,621 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Interest rate derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 1,003 | 1,755 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 486 | 734 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Equity derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 3,876 | 3,984 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 3,281 | 3,511 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Foreign exchange derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 18 | 18 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 1 | 2 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Credit derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 26 | 1 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 1 | |||||||||||||||
RiverSource Life | Recurring basis [Member] | Fixed deferred indexed annuity embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 56 | 52 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | IUL embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 949 | 935 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | GMWB and GMAB embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 715 | [5] | 2,316 | [6] | ||||||||||||
RiverSource Life | Recurring basis [Member] | Structured annuity embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 124 | 70 | [6] | |||||||||||||
RiverSource Life | Recurring basis [Member] | Corporate debt securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 12,628 | 12,873 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Residential mortgage backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 2,739 | 3,002 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Commercial mortgage backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 4,052 | 4,166 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | State and municipal obligations [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1,264 | 1,344 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Asset backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1,103 | 1,212 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Foreign government bonds and obligations [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 245 | 257 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | U.S. government and agencies obligations [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1 | |||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 1 [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1 | |||||||||||||||
Cash equivalents | 1,504 | 2,419 | ||||||||||||||
Other assets: derivative contracts | 334 | 408 | ||||||||||||||
Total assets at fair value | 1,838 | 2,828 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 151 | 184 | ||||||||||||||
Total liabilities at fair value | 151 | 184 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 1 [Member] | Interest rate derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 1 | |||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 1 | |||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 1 [Member] | Equity derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 333 | 406 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 149 | 182 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 1 [Member] | Foreign exchange derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 1 | 1 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 1 | 2 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 1 [Member] | U.S. government and agencies obligations [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1 | |||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 20,836 | 21,684 | ||||||||||||||
Cash equivalents | 692 | 713 | ||||||||||||||
Other assets: derivative contracts | 4,589 | 5,350 | ||||||||||||||
Total assets at fair value | 26,117 | 27,747 | ||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 4 | 3 | ||||||||||||||
Other liabilities: derivative contracts | 3,617 | 4,064 | ||||||||||||||
Total liabilities at fair value | 3,621 | 4,067 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Interest rate derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 1,003 | 1,754 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 485 | 734 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Equity derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 3,543 | 3,578 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 3,132 | 3,329 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Foreign exchange derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 17 | 17 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Credit derivative contracts [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Other assets: derivative contracts | 26 | 1 | ||||||||||||||
Liabilities | ||||||||||||||||
Other liabilities: derivative contracts | 1 | |||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Fixed deferred indexed annuity embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 4 | 3 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Corporate debt securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 11,821 | 12,107 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Residential mortgage backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 2,730 | 2,993 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Commercial mortgage backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 4,052 | 4,166 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | State and municipal obligations [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1,264 | 1,344 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Asset backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 724 | 817 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 2 [Member] | Foreign government bonds and obligations [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 245 | 257 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 1,195 | 1,170 | ||||||||||||||
Total assets at fair value | 1,195 | 1,170 | ||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 1,840 | 3,370 | ||||||||||||||
Total liabilities at fair value | 1,840 | 3,370 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | Fixed deferred indexed annuity embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 52 | 49 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | IUL embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 949 | 935 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | GMWB and GMAB embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 715 | 2,316 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | Structured annuity embedded derivatives [Member] | ||||||||||||||||
Liabilities | ||||||||||||||||
Policyholder account balances, future policy benefits and claims | 124 | 70 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | Corporate debt securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 807 | 766 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | Residential mortgage backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | 9 | 9 | ||||||||||||||
RiverSource Life | Recurring basis [Member] | Level 3 [Member] | Asset backed securities [Member] | ||||||||||||||||
Assets | ||||||||||||||||
Available-for-Sale securities | $ 379 | $ 395 | ||||||||||||||
|
Fair Values of Assets and Liabilities (Level 3 rollforwards-Assets) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Corporate debt securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | $ 735 | |
Total Gains (Losses) Included in Net Income | 0 | |
Total gains (losses) included in other comprehensive income (loss) | (6) | |
Purchases | 6 | |
Settlements | (14) | |
RiverSource Life | Corporate debt securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | $ 766 | 735 |
Total gains (losses) included in other comprehensive income (loss) | (5) | (6) |
Purchases | 46 | 6 |
Settlements | (14) | |
Balance, at the end of the period | 807 | 721 |
Changes in unrealized gains (losses) in net income relating to assets held at the end of the period | (5) | (6) |
RiverSource Life | Residential mortgage backed securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 9 | 17 |
Total gains (losses) included in other comprehensive income (loss) | 0 | 0 |
Balance, at the end of the period | 9 | 17 |
RiverSource Life | Asset backed securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 395 | 389 |
Total gains (losses) included in other comprehensive income (loss) | 3 | (89) |
Settlements | (19) | |
Balance, at the end of the period | 379 | 300 |
Changes in unrealized gains (losses) in net income relating to assets held at the end of the period | 3 | (89) |
RiverSource Life | Available-for-Sale Securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 1,170 | 1,141 |
Total gains (losses) included in other comprehensive income (loss) | (2) | (95) |
Purchases | 46 | 6 |
Settlements | (19) | (14) |
Balance, at the end of the period | 1,195 | 1,038 |
Changes in unrealized gains (losses) in net income relating to assets held at the end of the period | $ (2) | $ (95) |
Fair Values of Assets and Liabilities (Level 3 rollforwards-Liabilities) (Details) - RiverSource Life - USD ($) $ in Millions |
3 Months Ended | |||||
---|---|---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ||||||
Net increase (decrease) to pretax income from adjustment for nonperformance risk on the fair value of embedded derivatives | $ (167) | $ 1,800 | ||||
Fixed deferred indexed annuity embedded derivatives [Member] | ||||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ||||||
Balance at the beginning of the period | 49 | 43 | ||||
Total (gains) losses included in net income | [1] | 4 | (12) | |||
Issues | 2 | |||||
Settlements | (1) | |||||
Balance at the end of the period | 52 | 33 | ||||
IUL embedded derivatives [Member] | ||||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ||||||
Balance at the beginning of the period | 935 | 881 | ||||
Total (gains) losses included in net income | [1] | 29 | (145) | |||
Issues | 5 | 8 | ||||
Settlements | (20) | (19) | ||||
Balance at the end of the period | 949 | 725 | ||||
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period | [1] | 29 | (145) | |||
GMWB and GMAB embedded derivatives [Member] | ||||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ||||||
Balance at the beginning of the period | 2,316 | 763 | ||||
Total (gains) losses included in net income | [2] | (1,729) | 2,420 | |||
Issues | 90 | 88 | ||||
Settlements | 38 | 5 | ||||
Balance at the end of the period | 715 | 3,276 | ||||
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period | [2] | (1,705) | 2,423 | |||
Structured annuity embedded derivatives [Member] | ||||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ||||||
Balance at the beginning of the period | 70 | 0 | ||||
Total (gains) losses included in net income | [2] | 75 | (3) | |||
Issues | (15) | (6) | ||||
Settlements | (6) | |||||
Balance at the end of the period | 124 | (9) | ||||
Policyholder account balances, future policy benefits and claims [Member] | ||||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ||||||
Balance at the beginning of the period | 3,370 | 1,687 | ||||
Total (gains) losses included in net income | (1,621) | 2,260 | ||||
Issues | 80 | 92 | ||||
Settlements | 11 | (14) | ||||
Balance at the end of the period | 1,840 | 4,025 | ||||
Changes in unrealized (gains) losses in net income relating to liabilities held at the end of the period | $ (1,676) | $ 2,278 | ||||
|
Fair Values of Assets and Liabilities (Unobservable inputs) (Details) - RiverSource Life $ in Millions |
Mar. 31, 2021
USD ($)
|
Dec. 31, 2020
USD ($)
|
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, fair value | $ 22,031 | $ 22,855 | ||||||||||||||||
Corporate debt securities (private placements) [Member] | Discounted cash flow [Member] | Level 3 [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, fair value | $ 806 | $ 766 | ||||||||||||||||
Corporate debt securities (private placements) [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Yield/spread to U.S. Treasuries [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 0.009 | 0.010 | ||||||||||||||||
Corporate debt securities (private placements) [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Yield/spread to U.S. Treasuries [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 0.029 | 0.033 | ||||||||||||||||
Corporate debt securities (private placements) [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Yield/spread to U.S. Treasuries [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | [1] | 0.013 | 0.015 | |||||||||||||||
Asset backed securities [Member] | Discounted cash flow [Member] | Level 3 [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, fair value | $ 379 | $ 395 | ||||||||||||||||
Asset backed securities [Member] | Discounted cash flow [Member] | Level 3 [Member] | Annual default rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 0.056 | 0.053 | ||||||||||||||||
Asset backed securities [Member] | Discounted cash flow [Member] | Level 3 [Member] | Loss severity [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 0.250 | 0.250 | ||||||||||||||||
Asset backed securities [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Yield/spread to swap rates [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 1.75 | 2.50 | ||||||||||||||||
Asset backed securities [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Yield/spread to swap rates [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 3 | 4 | ||||||||||||||||
Asset backed securities [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Annual default rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 0.056 | 0.053 | ||||||||||||||||
Asset backed securities [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Loss severity [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | 0.250 | 0.250 | ||||||||||||||||
Asset backed securities [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Yield/spread to swap rates [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Fixed maturities, measurement inputs | [2] | 1.83 | 2.59 | |||||||||||||||
IUL embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives | $ 949 | $ 935 | ||||||||||||||||
IUL embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
IUL embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
Fixed deferred indexed annuity embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives | $ 52 | $ 49 | ||||||||||||||||
Fixed deferred indexed annuity embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
Fixed deferred indexed annuity embedded derivatives [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | 0.000 | 0.000 | ||||||||||||||||
Fixed deferred indexed annuity embedded derivatives [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | 0.500 | 0.500 | ||||||||||||||||
Fixed deferred indexed annuity embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
Fixed deferred indexed annuity embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [4] | 0.016 | 0.012 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives | $ 715 | $ 2,316 | ||||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | 0.001 | 0.001 | ||||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Utilization of guaranteed withdrawals [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [5] | 0.000 | 0.000 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Market volatility [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [6] | 0.042 | 0.043 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | 0.735 | 0.735 | ||||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Utilization of guaranteed withdrawals [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [5] | 0.480 | 0.480 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Market volatility [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [6] | 0.170 | 0.171 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [4] | 0.039 | 0.038 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Utilization of guaranteed withdrawals [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [5],[7] | 0.106 | 0.106 | |||||||||||||||
GMWB and GMAB embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Market volatility [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [6],[8] | 0.108 | 0.110 | |||||||||||||||
Structured annuity embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives | $ 124 | $ 70 | ||||||||||||||||
Structured annuity embedded derivatives [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
Structured annuity embedded derivatives [Member] | Minimum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | 0.008 | 0.008 | ||||||||||||||||
Structured annuity embedded derivatives [Member] | Maximum [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | 0.400 | 0.400 | ||||||||||||||||
Structured annuity embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Nonperformance risk [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [3] | 0.65 | 0.65 | |||||||||||||||
Structured annuity embedded derivatives [Member] | Weighted average [Member] | Discounted cash flow [Member] | Level 3 [Member] | Surrender rate [Member] | ||||||||||||||||||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||||||||||||||||
Embedded derivatives, measurement inputs | [4] | 0.009 | 0.009 | |||||||||||||||
|
Fair Values of Assets and Liabilities Fair Value of Assets & Liabilities (Non-Recurring) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Assets and liabilities measured at fair value | ||
Assets | $ 133,940 | $ 134,424 |
Affordable Housing And Other Real Estate Limited Partnership Interests | VIEs, not primary beneficiary [Member] | ||
Assets and liabilities measured at fair value | ||
Assets | 187 | 200 |
Affordable Housing And Other Real Estate Limited Partnership Interests | Nonrecurring basis [Member] | Level 3 [Member] | VIEs, not primary beneficiary [Member] | ||
Assets and liabilities measured at fair value | ||
Assets | $ 97 | $ 101 |
Fair Values of Assets and Liabilities (Financial Instruments not at FV) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
---|---|---|
Financial Liabilities | ||
Separate account liabilities - investment contracts | $ 88,433 | $ 87,556 |
RiverSource Life | ||
Financial Assets | ||
Mortgage loans, net | 2,541 | 2,574 |
Policy loans | 838 | 846 |
Other investments | 662 | 701 |
Other receivables | 1,620 | 1,613 |
Financial Liabilities | ||
Short-term borrowings | 200 | 200 |
Long-term debt | 500 | 500 |
Other liabilities | 6,441 | 6,887 |
Separate account liabilities - investment contracts | 88,433 | 87,556 |
RiverSource Life | Carrying value [Member] | ||
Financial Assets | ||
Mortgage loans, net | 2,541 | 2,574 |
Policy loans | 838 | 846 |
Other investments | 434 | 457 |
Other receivables | 1,411 | 1,430 |
Financial Liabilities | ||
Policyholder account balances, future policy benefits and claims | 10,499 | 9,990 |
Short-term borrowings | 200 | 200 |
Long-term debt | 500 | 500 |
Other liabilities | 11 | 12 |
Separate account liabilities - investment contracts | 369 | 351 |
RiverSource Life | Estimate of Fair Value Measurement [Member] | ||
Financial Assets | ||
Mortgage loans, net | 2,627 | 2,724 |
Policy loans | 838 | 846 |
Other investments | 433 | 457 |
Other receivables | 1,648 | 1,732 |
Financial Liabilities | ||
Policyholder account balances, future policy benefits and claims | 11,630 | 11,686 |
Short-term borrowings | 200 | 200 |
Long-term debt | 449 | 509 |
Other liabilities | 11 | 11 |
Separate account liabilities - investment contracts | 369 | 351 |
RiverSource Life | Level 2 [Member] | Estimate of Fair Value Measurement [Member] | ||
Financial Assets | ||
Policy loans | 838 | 846 |
Other investments | 397 | 417 |
Financial Liabilities | ||
Short-term borrowings | 200 | 200 |
Long-term debt | 449 | 509 |
Separate account liabilities - investment contracts | 369 | 351 |
RiverSource Life | Level 3 [Member] | Estimate of Fair Value Measurement [Member] | ||
Financial Assets | ||
Mortgage loans, net | 2,627 | 2,724 |
Other investments | 36 | 40 |
Other receivables | 1,648 | 1,732 |
Financial Liabilities | ||
Policyholder account balances, future policy benefits and claims | 11,630 | 11,686 |
Other liabilities | $ 11 | $ 11 |
Offsetting Assets and Liabilities (Assets) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
|||||
---|---|---|---|---|---|---|---|
Derivatives: | |||||||
Gross amounts of recognized assets | $ 4,923 | [1] | $ 5,758 | ||||
OTC derivatives [Member] | |||||||
Derivatives: | |||||||
Gross amounts of recognized assets | 4,638 | 5,391 | |||||
Gross Amounts Not Offset in the Consolidated Balance Sheets | |||||||
Financial instruments | (3,305) | (3,801) | |||||
Cash collateral | (1,073) | (1,243) | |||||
Securities collateral | (252) | (315) | |||||
Net amount | 8 | 32 | |||||
OTC cleared derivatives [Member] | |||||||
Derivatives: | |||||||
Gross amounts of recognized assets | 39 | 58 | |||||
Gross Amounts Not Offset in the Consolidated Balance Sheets | |||||||
Financial instruments | (39) | (25) | |||||
Net amount | 0 | 33 | |||||
Exchange-traded derivatives [Member] | |||||||
Derivatives: | |||||||
Gross amounts of recognized assets | 246 | 309 | |||||
Gross Amounts Not Offset in the Consolidated Balance Sheets | |||||||
Financial instruments | (107) | (90) | |||||
Cash collateral | (133) | (165) | |||||
Net amount | 6 | 54 | |||||
Total derivatives [Member] | |||||||
Derivatives: | |||||||
Gross amounts of recognized assets | 4,923 | 5,758 | |||||
Gross Amounts Not Offset in the Consolidated Balance Sheets | |||||||
Financial instruments | [2] | (3,451) | (3,916) | ||||
Cash collateral | (1,206) | (1,408) | |||||
Securities collateral | (252) | (315) | |||||
Net amount | $ 14 | $ 119 | |||||
|
Offsetting Assets and Liabilities (Liabilities) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
||
---|---|---|---|---|
OTC derivatives [Member] | ||||
Derivatives | ||||
Gross amounts of recognized liabilities | $ 3,580 | $ 4,129 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | (3,305) | (3,801) | ||
Cash collateral | (3) | (1) | ||
Securities collateral | (258) | (327) | ||
Net amount | 14 | 0 | ||
OTC cleared derivatives [Member] | ||||
Derivatives | ||||
Gross amounts of recognized liabilities | 76 | 25 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | (39) | (25) | ||
Net amount | 37 | 0 | ||
Exchange-traded derivatives [Member] | ||||
Derivatives | ||||
Gross amounts of recognized liabilities | 112 | 94 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | (108) | (90) | ||
Net amount | 4 | 4 | ||
Total derivatives [Member] | ||||
Derivatives | ||||
Gross amounts of recognized liabilities | 3,768 | 4,248 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [1] | (3,452) | (3,916) | |
Cash collateral | (3) | (1) | ||
Securities collateral | (258) | (327) | ||
Net amount | $ 55 | $ 4 | ||
|
Derivatives and Hedging Activities (Balance Sheet) (Details) - USD ($) $ in Millions |
Mar. 31, 2021 |
Dec. 31, 2020 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Derivatives and Hedging Activities | |||||||||||
Notional amount | $ 134,769 | $ 139,311 | |||||||||
Gross fair value of assets | 4,923 | [1] | 5,758 | ||||||||
Total derivatives | [2],[3] | 5,612 | 7,621 | ||||||||
Derivative liability after application of master netting arrangements and cash collateral including embedded derivative liabilities | 2,200 | 3,700 | |||||||||
Fair value of investment securities received as collateral | 292 | ||||||||||
Fair value of investment securities received as collateral that can be repledged | 292 | 325 | |||||||||
Fair value of investment securities received as collateral that were repledged | 0 | 0 | |||||||||
GMWB and GMAB embedded derivatives [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of assets | 265 | 67 | |||||||||
Gross fair value of liabilities | 980 | 2,400 | |||||||||
Derivatives not designated as hedging instruments [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Notional amount | 134,769 | 139,311 | |||||||||
Derivatives not designated as hedging instruments [Member] | Interest rate contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Notional amount | 79,798 | 77,925 | |||||||||
Derivatives not designated as hedging instruments [Member] | Equity contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Notional amount | 50,327 | 55,993 | |||||||||
Derivatives not designated as hedging instruments [Member] | Credit contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Notional amount | 2,064 | 2,269 | |||||||||
Derivatives not designated as hedging instruments [Member] | Foreign exchange contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Notional amount | 2,580 | 3,124 | |||||||||
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of assets | [1] | 4,923 | 5,758 | ||||||||
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Interest rate contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of assets | [1] | 1,003 | 1,755 | ||||||||
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Equity contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of assets | [1] | 3,876 | 3,984 | ||||||||
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Credit contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of assets | [1] | 26 | 1 | ||||||||
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Foreign exchange contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of assets | [1] | 18 | 18 | ||||||||
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of liabilities | [2],[3] | 3,768 | 4,248 | ||||||||
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Interest rate contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of liabilities | [2],[3] | 486 | 734 | ||||||||
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Equity contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of liabilities | [2],[3] | 3,281 | 3,511 | ||||||||
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Credit contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of liabilities | [2],[3] | 1 | |||||||||
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Foreign exchange contracts [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of liabilities | [2],[3] | 1 | 2 | ||||||||
Policyholder account balances, future policy benefits and claims [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of embedded derivative liabilities | [2],[3] | 1,844 | 3,373 | ||||||||
Policyholder account balances, future policy benefits and claims [Member] | GMWB and GMAB embedded derivatives [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of embedded derivative liabilities | [2],[3],[4] | 715 | 2,316 | ||||||||
Policyholder account balances, future policy benefits and claims [Member] | IUL embedded derivatives [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of embedded derivative liabilities | [2],[3] | 949 | 935 | ||||||||
Policyholder account balances, future policy benefits and claims [Member] | Fixed deferred indexed annuity embedded derivatives [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of embedded derivative liabilities | [2],[3] | 56 | 52 | ||||||||
Policyholder account balances, future policy benefits and claims [Member] | Structured annuity embedded derivatives [Member] | |||||||||||
Derivatives and Hedging Activities | |||||||||||
Gross fair value of embedded derivative liabilities | [2],[3] | $ 124 | $ 70 | ||||||||
|
Derivatives and Hedging Activities (Income Statement) (Details) - Derivatives not designated as hedging instruments [Member] - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Net Investment Income | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | $ 1 | |
Net Investment Income | Equity contracts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 1 | |
Interest credited to fixed accounts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 11 | $ 64 |
Interest credited to fixed accounts [Member] | Equity contracts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 25 | (112) |
Interest credited to fixed accounts [Member] | IUL embedded derivatives [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (9) | 164 |
Interest credited to fixed accounts [Member] | Fixed deferred indexed annuity embedded derivatives [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (5) | 12 |
Benefits, claims, losses and settlement expenses [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (530) | 2,006 |
Benefits, claims, losses and settlement expenses [Member] | Interest rate contracts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (1,825) | 2,515 |
Benefits, claims, losses and settlement expenses [Member] | Equity contracts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (310) | 1,993 |
Benefits, claims, losses and settlement expenses [Member] | Credit contracts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 69 | (36) |
Benefits, claims, losses and settlement expenses [Member] | Foreign exchange contracts [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 11 | 44 |
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB embedded derivatives [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 1,600 | (2,513) |
Benefits, claims, losses and settlement expenses [Member] | Structured annuity embedded derivatives [Member] | ||
Impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | $ (75) | $ 3 |
Derivatives and Hedging Activities (Option Pay/Rec) (Details) $ in Millions |
Mar. 31, 2021
USD ($)
|
|||
---|---|---|---|---|
Summary of option premiums payable and receivable | ||||
Premiums payable | $ 893 | |||
Premiums receivable | 467 | |||
2021 [Member] | ||||
Summary of option premiums payable and receivable | ||||
Premiums payable | 112 | [1] | ||
Premiums receivable | 85 | [1] | ||
2022 [Member] | ||||
Summary of option premiums payable and receivable | ||||
Premiums payable | 205 | |||
Premiums receivable | 205 | |||
2023 [Member] | ||||
Summary of option premiums payable and receivable | ||||
Premiums payable | 51 | |||
Premiums receivable | 42 | |||
2024 [Member] | ||||
Summary of option premiums payable and receivable | ||||
Premiums payable | 138 | |||
Premiums receivable | 25 | |||
2025 [Member] | ||||
Summary of option premiums payable and receivable | ||||
Premiums payable | 125 | |||
Premiums receivable | 22 | |||
2026-2028 [Member] | ||||
Summary of option premiums payable and receivable | ||||
Premiums payable | 262 | |||
Premiums receivable | $ 88 | |||
|
Derivatives and Hedging Activities (Cash Flow Hedges and Credit Risk) (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Cash Flow Hedges | |||
Derivatives designated as cash flow hedges | $ 0 | $ 0 | |
Hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy | 0 | $ 0 | |
Derivatives liabilities, credit risk related contingent features | |||
Aggregate fair value of all derivative instruments containing credit risk features | 261 | $ 324 | |
Aggregate fair value of assets posted as collateral | 258 | 324 | |
Aggregate fair value of assets needed to settle derivative liabilities | $ 3 | $ 0 |
Shareholder's Equity (Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
|
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent [Abstract] | ||
Net unrealized gains (losses) on securities arising during the period, pretax | $ (678) | $ (1,002) |
Reclassification of net (gains) losses on securities included in net income, pretax | (49) | (8) |
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, pretax | 299 | 508 |
Net unrealized gains (losses) on securities, pretax | (428) | (502) |
Total other comprehensive income (loss), pretax | (428) | (502) |
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent [Abstract] | ||
Net unrealized gains (losses) on securities arising during the period, tax | 142 | 212 |
Reclassification of net (gains) losses on securities included in net income, tax | 11 | 2 |
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, tax | (63) | (107) |
Net unrealized gains (losses) on securities, tax | 90 | 107 |
Total other comprehensive income (loss), tax | 90 | 107 |
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract] | ||
Net unrealized gains (losses) on securities arising during the period, net of tax | (536) | (790) |
Reclassification of net (gains) losses on securities included in net income, net of tax | (38) | (6) |
Impact of DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, net of tax | 236 | 401 |
Net unrealized gains (losses) on securities, net of tax | (338) | (395) |
Total other comprehensive income (loss), net of tax | $ (338) | $ (395) |
Shareholder's Equity (Reclassifications) (Details) - USD ($) $ in Millions |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | $ 920 | $ 574 | ||
OCI before reclassifications | (300) | (389) | ||
Amounts reclassified from AOCI | (38) | (6) | ||
Total OCI | (338) | (395) | ||
Ending balance | 582 | 179 | ||
Stockholders' Equity Attributable to Parent | 2,743 | 4,478 | $ 3,313 | $ 3,336 |
Net unrealized gains (losses) on securities [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
OCI before reclassifications | (300) | (389) | ||
Amounts reclassified from AOCI | (38) | (6) | ||
Total OCI | (338) | (395) | ||
Ending balance | 583 | 180 | ||
Stockholders' Equity Attributable to Parent | 921 | 575 | ||
Other [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
OCI before reclassifications | 0 | 0 | ||
Amounts reclassified from AOCI | 0 | 0 | ||
Total OCI | 0 | 0 | ||
Ending balance | $ (1) | $ (1) | ||
Stockholders' Equity Attributable to Parent | $ (1) | $ (1) |
Income Taxes (Details) - USD ($) $ in Millions |
3 Months Ended | ||
---|---|---|---|
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
Income taxes | |||
Effective tax rate (as a percent) | 9.10% | 8.50% | |
Benefit related to forecasted utilization of a 2020 NOL | $ 160 | ||
Valuation allowance | $ 11 | $ 11 | |
Gross unrecognized tax benefits | 38 | 38 | |
Unrecognized tax benefits, net of federal tax benefits, that would affect the effective tax rate if recognized | 20 | 20 | |
Decrease in Unrecognized Tax Benefits is Reasonably Possible | 33 | ||
Interest and penalties recognized in income tax provision | 0 | $ 0 | |
Payable related to accrued interest and penalties | 2 | $ 2 | |
State and local jurisdiction [Member] | |||
Income taxes | |||
Deferred tax assets, loss carryforwards | 9 | ||
Valuation allowance | 2 | ||
Valuation allowance, net operating losses | $ 9 |
Contingencies (Details) - Estimated guaranty fund assessments [Member] - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
---|---|---|
Mar. 31, 2021 |
Dec. 31, 2020 |
|
Contingencies | ||
Estimated liability related to guaranty fund assessments | $ 12 | $ 12 |
Related premium tax asset | $ 10 | $ 10 |
.TVW6>R+
M/9+( UKI 5MP **$P)MD2@30C$Y ;D<+$]#I1=:,-
M,%.4E#'U5'^4NM@R=SHKE%$6!,B"N(EU! 8QP]K0DZ.HX@9M(%^,^=]?Q@T.^Y4:Q"':G
MX.<)?N5'\(R^7X4C\=O@9M"=3-.PZ&RVZ4M]SZU;,;JNZ45#NG B*+>U3OT#
MMXS#4+S/ZN1&CN>(
1EU@-]4S8DB-TV0(2@>"0*1TA K
MF\9QC:*#7.Z_/- +?%H]'+L6]\?^L_NPG_V( ^W1_B(W[O8Y/QL'<(LRG^EW
M%[DTV@,N^3B-VL["X!6XWE%#II;K4'@\!C"[QPE\X-C9+/H'$76'TQ'_E%E%
MA76C3CIU$%=+:1;J.86"S3#M\!WE;Q%,TS*%C_1)#CN#)DFB;0[<9H3^"NM*
MH"0=W6I 6.I ;/, ,$Z'44^8(:=(\4E1,-9F6O )#KG!T0B]$XNV2\']&;B/
MGNN9L#L
:"M6M
M6-:E,:*IV%B9ETV!,_*!!<$%*5)5L^&5JE,%'Y:*@M#Y*Y2L"UTLC2?6*YVN
MA*P5@8FJ*0:V%-*()?M->GZ$GMZ_ZT^]>ZUQ<.X&0#*?:T(4;R=^K9.;.+-O
MU[=W5WS_U[>75P>CA+N\UV5CLH?^=C9RVHN!#T_=C2[2,E=/7,[-TY?SIHW6
MIW^)JLQT2K=P(".8;:Z$43!A#L3>Z-\*"/GQU E%":_<)7K _-GOP&$*N*E4
MJA?:^>@B:5PHV: '!"[+1%'BL*KAIK2*(\AD"H8N&D6".OOD7@:I>U4(S76
MN]8&,3+-8D&^4NXX)?M.N>[S $E:URJ'WER$
M+GTU2)*!.T"2\\#7KY^-))?.
LAG!(QR=5!H6/.U>U3%6@R*<3BFZXSW8_RO3H+RF
MIN3][@@>KX%D33@'&KSGISM]&/]A+9Q1C'>"P_#VXJ8L+%_VK'\K6?^YCZVK
MO;^405LFO+NU;%[NVH$_A"[HU@N[JDK9+CS+RC.A$LM99H'DC@\=CC;N1U1T
M?OUE3#7H3=6:U45^-YMXAA!E:\I*LE\QWF7D
M0#S7FQ=)'XQ,5*8].8+8"KC=2.H,
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M^*C9A%.?<8.J/)"1_0D* M&U8J\)
MG%Z"U4.\J,K"NXI2G V!?CTY])8^'7SS0#5K_K(#Z$C#TN>/_F[_\>@Z?3-Y
M6)Z^/&&6$!UO=*J Z6SRZG0D?/J:DRZBJ_D+"B8ONHI_EDJB3EJ YX5SL;N@
M /TGM:N_ %!+ P04 " #X>JI2+FD_F9<& #$ &0 'AL+W=O